posts tagged:


lifescience


(search for keywords instead, or create an alert on this tag)

Monday, October 20, 2014

ZipLine Medical Finds $5.7M

Campbell, California-based ZipLine Medical has added $5.7M to a current, Series C financing round, the company announced this morning. Zipline said the extension to its round came from China Materialia, and also included RA Capital Manageme...

READ MORE...
Thursday, October 16, 2014

MID Labs Sees $51M

San Leandro-based MID Labs said today that it has raised $51M in funding for its medical devices. The company, which develops products for vitreoretinal surgery, said the funding was led by OrbiMed and Frontline BioVentures, and also includ...

READ MORE...
Tuesday, October 14, 2014

Invitae Finds $120M For Genetic Testing

San Francisco-based Invitae, a provider of genetic testing services for hereditary disorders, said today that it has raised $120M in a funding round. The Series F funding came from The Broe Group, Decheng Capital, Deerfield Management LLC, ...

READ MORE...
Tuesday, September 30, 2014

Allakos Gets $10M More

San Mateo-based Allakos, a biotechnology company developing antibody-based therapeutics for allergic diseases, inflammation, and other related conditions, said today that it has raised $10M more in a Series A funding. The new funds bring it...

READ MORE...
Tuesday, September 23, 2014

Jiff Gets $18M For Employee Health Tools

Palo Alto-based Jiff, a developer of cloud-based tools to help employees of self-insured employers better manage their health, has raised $18M in a Series B funding round. The funding came from Venrock, Aberdare Ventures, and Aeris Capital....

READ MORE...
Friday, September 19, 2014

Calithera Biosciences Sets IPO Pricing Range

South San Francisco-based biopharmaceuticals developer Calithera Biosciences has set its estimated IPO range, saying in a filing that it now expects to price at between $13.00 and $15.00 per share. The company is selling 6 million shares of...

READ MORE...
Thursday, September 11, 2014

Livongo Health Gets $10M To Better Manage Diabetes

Palo Alto-based Livongo Health, a company developing a service to help patients manage chronic conditions such as diabetes, has raised $10M in a funding round, the company said this week. The funding came from 7wire Ventures and General Cat...

READ MORE...
Thursday, August 28, 2014

Armetheon Finds $7M

Menlo Park-based Armetheon, a developer of biopharmceuticals aimed at treating cardiovascular conditions, has raised $7.0M in a first round of funding. The company said that the round was co-led by AshHill Biomedical Investments and Hercule...

READ MORE...
Monday, August 25, 2014

Omnicell Completes Surgichem Buy

Mountain View-based Omnicell said this morning that it has completed its acquisition of Surgichem Limited, which is a subsidiary of Bupa Care Homes (CFG) plc. Financial details of the buy were not announced. Omnicell is a provider of medica...

READ MORE...
Friday, August 22, 2014

Dermira Pulls Up $51M

Redwood City-base dDermira, a biopharmaceuticals firm focused on medical dermatology, said this week that it has raised $51M in a Series C funding round. The funding came from Bay City Capital, New Enterprise Associates (NEA), Canaan, and U...

READ MORE...
Tuesday, August 19, 2014

Nirmidas Biotech Finds $2M

San Francisco-based Nirmidas Biotech, a company developing technology for detecting disease biomarkers, has raised $2m in a seed funding round. The company--which is based on research out of Stanford--said the funding came from the Stanford...

READ MORE...
Tuesday, August 12, 2014

Acupera Raises $4M For Health Software

San Francisco-based Acupera said this morning that it has raised $4M in a financing round, for its clinical analytics and workflow engine for the healthcare industry. The funding came from Lightspeed Venture Partners and The Whittemore Coll...

READ MORE...
Tuesday, July 29, 2014

PaxVax Gets $62M For Vaccine Efforts

Redwood City-based PaxVax, a developer of vaccines for infectious disease, has raised $62M in funding, split between $50M in secured debt financing and $12M in an extension of its Series B funding round. The company said the debt financing ...

READ MORE...
Wednesday, July 16, 2014

Virobay Gets $8M In Additional Series B

Menlo Park-based Virobay, which is developing pharmaceuticals to treat neuropathic pain, autoimmune disease and fibrosis, has raised $8M in an additional, Series B funding. The funding came from Perceptive Advisors, as well as existing inv...

READ MORE...
Wednesday, July 2, 2014

Emerald Therapeutics Raises $13.5M For Robotic Wet Labs

Menlo Park-bsaed Emerald Therapeutics said Tuesday that it has raised a new round of funding, bringing its total raised to a total of $13.5M. The funding was led by Founders Fund and Max Levchin, and also included Schooner Capital. Emerland...

READ MORE...
Friday, June 27, 2014

Consano Medical Scores $3.9M For Intensive Care Monitoring

San Francisco-based Consano Medical, a developer of medical devices focused on the intelligent monitoring of intensive care unit patients, has raised $3.9M in a Series A funding, according to deal funding site Deal Labs. Source of the fundi...

READ MORE...
Wednesday, June 18, 2014

True North Therapeutics Gets $22M

South San Francisco-based biotechnology developer True North Therapeutics said yesterday that it has raised $22M in a Series A funding round. The funding came from Kleiner Perkins Caufield & Byers, MPM Capital, SR One, Biogen Idec New Ventu...

READ MORE...
Friday, June 13, 2014

Chrono Therapeutics Gets $32M For Smoking Cessation

Hayward-based Chrono Therapeutics, which is developing products to help patients with quitting smoking, said Thursday that it has raised $32M in a Series A funding round. The funding came from Canaan Partners, 5AM Ventures, Fountain Healthc...

READ MORE...
Wednesday, June 4, 2014

MedGenome Gets $4M For Cancer Diagnostics

San Francisco-based MedGenome, which is using genetic information in India to better treat cancer in that country and elsewhere, has raised $4M in a Series A funding. THe company said the funding was led by Papillon Capital and Emerge Ventu...

READ MORE...
Tuesday, June 3, 2014

Proteus Digital Health Gets $120M

Redwood City-based Proteus Digital Health, a developer of software which connects patients, families, and caregivers, has raised $120M in a new funding, the company said Monday. The company said the funding came from major, new institutiona...

READ MORE...
Wednesday, May 28, 2014

AngioScore Acquired By Spectranetics

Fremont-based AngioScore, a devleoper and manufacturer of balloon catheters used for cardiac surgery, has been acquired by Spectranetics, the two said Tuesday. Spectranetics will pay $230M plus unspecified earnout for AngioScore. AngioScore...

READ MORE...
Tuesday, May 27, 2014

Twist Bioscience Gets $26M

San Francisco-based Twist Bioscience has raised $26M in a Series B financing, the company announced today, to go towards its semiconductor-based, synthetic DNA manufacturing technology. The funding was led by Nick and Joby Pritzker, through...

READ MORE...
Thursday, May 22, 2014

iRhythm Finds $17M

San Francisco-based iRhythm Technologies said today that it has raised $17M in a Series E financing round. The company, which develops products for continuous monitoring of cardiac arrhythmia, said the funding was led by Novo A/S, and also ...

READ MORE...
Wednesday, May 21, 2014

Mango Health Harvests $5.25M

San Francisco-based Mango Health, a developer of software that uses gamification and social gaming to encourage health in patients, announced this morning that it has raised $5.25M in a Series A funding. The funding was led by Kleiner Perki...

READ MORE...
Monday, May 12, 2014

Altos Solutions Acquired By Flatiron Health

Los Altos-based Altos Solutions, a developer of web-based, electronic medical records software, has been acquired by Flatiron Health. Financial details of the acquisition were not disclosed. Altos Solutions develops cancer/oncology focused ...

READ MORE...
Friday, May 9, 2014

EndoGastric Solutions Lands $30M

San Mateo-based EndoGastric Solutions, a developer of reconstructive treatments for gastroesophageal reflux disease (GERD), has raised $30M in a new funding round, the company said this week. The funding came from existing investors, includ...

READ MORE...
Friday, May 9, 2014

Counsyl Gets $28M For Genetic Testing Service

South San Francisco-based Counsyl, a provider of inherited, cancer screening testing services, said this week that it has raised $28M in a Series D financing round. The company said the new funding was co-led by Rosemont Seneca Technology P...

READ MORE...
Friday, May 2, 2014

ProteinSimple Files For IPO

Santa Clara-based ProteinSimple has filed for an IPO, saying yesterday that it is looking to raised up to $86.25M in an IPO on the NASDAQ Global Select Market as PRTN. The startup--which develops protein analysis software and tools--is vent...

READ MORE...
Tuesday, April 29, 2014

Doximity Gets $54M For Social Network For Doctors

San Francisco-based Doximity, which operates an online, private social network specifically for doctors, has raised $54M in a funding round, the company said Tuesday. The Series C funding round was co-led by Draper Fisher Jurvetson and T. R...

READ MORE...
Monday, April 28, 2014

SI-BONE Connects With $33M

San Jose-based SI-BONE, a developer of medical devices used for back surgery, has raised $33M more in funding, the company said today. SI-BONE said the funding came from Orbimed and Novo A/S, and also included prior investors Skyline Ventur...

READ MORE...
Wednesday, April 23, 2014

Guardant Health Snags $30M For Tumor Sequencing

Redwood City-based Guardant Health has raised $30M in a Series B funding, to go towards development of a no-invasive, tumor sequencing test. The funding was led by Khosla Ventures, and also included Sequoia Capital and Perjman Mar Ventures....

READ MORE...
Wednesday, April 23, 2014

Principia Biopharma Raises $50M

South San Francisco-based Principia Biopharma said yesterday that it has raised $50M in a Series B funding round. The company, which is developing small molecule biopharmaceuticals aimed at treating autoimmune diseases, said the funding was...

READ MORE...
Thursday, April 17, 2014

One Medical Group Books $40M In Funding

San Francisco-based One Medical Group, which operates a network of doctor's offices aimed at primary care, has raised $40M in a funding round. The new funding came from Redmile Group, and also included Google Ventures, Benchmark, DAG Ventur...

READ MORE...
Thursday, April 17, 2014

ForSight VISION5 Finds $15M

Menlo Park-based Forsight VISION5, a developer of ocular inserts for treating glaucoma, dry eye, and allergy, said yesterday that it has raised $15M in a Series C funding round. The funding came from H.I.G. BioVentures, as well as Morgentha...

READ MORE...
Wednesday, April 16, 2014

Iconic Therapeutics Finds $20M

South San Francisco-based Iconic Therapeutics announced this morning that it has raised $20M in a Series B-1 funding round. The funds came from MPM Capital, Lundbeckfond Ventures, and H.I.G. BioVentures. Iconic Therapeutics is developing tr...

READ MORE...
Tuesday, April 8, 2014

Alios BioPharma Lands $41M In Series B

South San Francisco-based Alios BioPharma said Monday that it has raised $41M in a Series B funding round. The funding came from Novo Ventures, SR One, Roche Venture Fund, and Novartis Ventures. A new, undisclosed investor led the round. Al...

READ MORE...
Friday, April 4, 2014

Reflexion Medical Sees $11.6M For Medical Devices

Burlingame-based Reflexion Medical has snagged $11.6M in a Series A funding, for the company's medical devices for radiation therapy for treating cancer. The funding came from Sofinnova Partners, and also included Pfizer Venture Investments...

READ MORE...
Wednesday, April 2, 2014

Transcend Medical Gets $22M

Menlo Park-based Transcend Medical, a developer of micro-stents used to treat glaucoma, has raised $22M in a Series C funding. The company said the funding came from existing investors, as well as an un-named, global pharmaceutical and medi...

READ MORE...
Tuesday, April 1, 2014

Providence Medical Technology Finds $6.8M

Lafayette, California-based Providence Medical Technology, a developer of medical devices for the cervical fusion and back surgery market, has raised $6.8M in a Series C funding round. The funding came from Stanmore Medical Investments via ...

READ MORE...
Monday, March 17, 2014

PipelineRx Gets Strategic Investment

San Francisco-based PipelineRx, which provides outsourced, telepharmacy services to hospitals--allowing them to access remote pharmacists by phone to bolster onsite clinical pharmacists--has raised $5M in a strategic investment from AMN Hea...

READ MORE...
Wednesday, March 12, 2014

Achaogen Up In IPO

South San Francisco-based Achaogen raised $72M in its IPO, and was up in trading during the day, after debuting at $12 per share this morning on the NASDAQ Global Market as AKAO. The company, which develops antibiotics aimed at drug-resista...

READ MORE...
Tuesday, March 11, 2014

Versartis Sets IPO Range

Moutain View-based Versartis, a biopharmaceuticals firm developing treatment for endocrine disorders, has set its IPO range at between $16.00 and $19.00 per share. The startup said it is looking to list on the NASDAQ Global Market as VSAR. ...

READ MORE...
Tuesday, March 11, 2014

Castlight Health Ups IPO Pricing Range

San Francisco-based Castlight Health, which develops cloud-based enterprise healthcare management software, has upped its IPO pricing range, saying in a filing that it now expects to IPo at between $13.00 and $15.00 per share. The company i...

READ MORE...
Thursday, March 6, 2014

NVP Backs iCardiac Technologies

Palo Alto-based Norwest Venture Partners (NVP) is backing a New York-based company which provides cardiac safety assessment services, iCardiac, the two said today. Size of the investment was not disclosed. iCardiac said that they are in a p...

READ MORE...
Thursday, February 13, 2014

Miramar Labs Gets $10M

Sunnyvale-based Miramar Labs, a medical device manufacturer developing products to reduce excess sweat production, said yesterday that it has raised $10M in a Series D funding. The funding came from Aisling Capital, Cross Creek Capital, Dom...

READ MORE...
Thursday, February 6, 2014

Jaguar Animal Health Raises $2M

San Francisco-based Jaguar Animal Health, a developer of prescription pharmaceuticals and nutraceuticals for the veterinary marketplace, said it has raised $2M in a funding round. The fundin came from BioVeda China Fund. According to Jagura...

READ MORE...
Wednesday, February 5, 2014

Thoma Bravo Buys GHX

San Francisco-based private equity investor Thoma Bravo said this morning that it has acquired GHX, a provider of healthcare supply chain software and services. Financial details of the acquisition were not announced by the companies. GHX, ...

READ MORE...
Friday, January 10, 2014

NEA Bolsters Pharma Industry Expertise With New Venture Partner

Menlo Park-based venture investor New Enterprise Associates said this week that it has hired on Elliot Sigal, M.D., Ph.D., as a new Venture Partner and Senior Advisor, significantly bolstering the company's expertise in the pharmaceuticals ...

READ MORE...
Thursday, January 9, 2014

Glooko Finds $7M More

Palo Alto-based Glooko, a developer of mobile apps to help patients manage diabetes, has raised $7M more in its Series A, via a Series A1 round, the company disclosed this week. The funding came from Samsun venture Investment Company and Li...

READ MORE...
Wednesday, January 8, 2014

Lumiata Lands $4M For Predictive Analytics For Healthcare

San Mateo-based Lumiata, a developer of predictive analytics software for the the healthcare industry, reported today that it has raised $4M in a Series A financing. The financing came from Khosla Ventures. Lumiata was formerly known as MED...

READ MORE...
Wednesday, January 8, 2014

Zephyr Health Finds $15M

San Francisco-based big data analytics software developer Zephy Health said today that it has raised $15M in a funding round, for the company's platform aimed at life sciences companies. The startup said the funding was co-led by Kleiner Pe...

READ MORE...
Tuesday, January 7, 2014

Alverix Acquired By BD For $40M

San Jose-based Alverix, a developer of point-of-care diagnostic instruments, has been acquired in a $40M deal by BD (Becton, Dickinson and Company). According to BD, it has been using Alverix' instruments since 2008, as part of a collaborat...

READ MORE...
Thursday, December 19, 2013

AcelRx Gets $40M In Credit Facility

Redwood City-based pharmaceuticals developer AcelRx Pharmaceuticals said this morning that it has received a $40M credit facility from Hercules Technology Growth Capital. Terms of the new credit facility were not announced. AcelRx is develo...

READ MORE...
Wednesday, December 18, 2013

Soundhawk Picks Up $5.7M For Better Hearing Devices

San Francisco-based SoundHawk, which develops "smart" wireless hearing devices which connect hearing aids with a smartphone, has raised $5.7M in a funding round, the company announced Wednesday. The funding was led by True Ventures. The com...

READ MORE...
Monday, December 16, 2013

Solta Medical Acquired By Valeant Pharmaceuticals

Hayward-based Solta Medical has been acquired by Valeant Pharmaceuticals, in a deal worth approximately $250M. Valeant said it will pay $2.92 per share in cash for Solta, which develops aesthetic medicine medical devices, including RF devic...

READ MORE...
Monday, December 9, 2013

HealthLoop Gets $10M

Mountain View-based HealthLoop, a developer of a cloud-based platform for automating follow up care for physicians, has raised $10M in a Series A funding. The funding came from Canvas Venture Fund, which is managed by Morgenthaler Technolog...

READ MORE...
Monday, December 9, 2013

Practice Fusion Adds $15M

San Francisco-based health technology and electronic health records software provider Practice Fusion said this morning that it has raised $15M in a Series D funding round. The round was led by Qualcomm Incorporate, via its venture arm, Qua...

READ MORE...
Friday, November 15, 2013

GenapSys Raises $37M

Redwood City-based GenapSys said this week that it has raised $37M in a funding round for its gene sequencing platforms. The Series B funding came from Decheng Capital, IPV Capital, Yuri Milner, Stanford StartX Fund, and others. The company...

READ MORE...
Wednesday, October 30, 2013

Veracyte Slips Slightly In IPO Debut

South San Francisco-based Veracyte debuted this morning in its IPO, and was trading slightly down after pricing at $13.00 per share lsat night. Veracyte was trading around $12.95 in morning trading, after its IPO as VCYT on the NASDAQ Globa...

READ MORE...
Wednesday, October 30, 2013

Calithera Biosciences Finds $35M

South San Francisco-based Calithera Biosciences, a developer of cancer therapeutics, has raised $35M in its Series D funding round, the company announced. The company said the funding was led by Adage Capital Partners, and also included Lon...

READ MORE...
Wednesday, October 30, 2013

Immune Design Gets $49M For Cancer Therapy

San Francisco- and Seattle-based Immune Design said this morning that it has raised $49M in a funding round, to go towards its immune-based therapies for cancer and other conditions. The Series C funding came from The Column Group, and also...

READ MORE...
Monday, October 28, 2013

NextBio Acquired By Illumina

Santa Clara-based NextBio, a developer of big data platforms for the clinical and genomic information market, has been acquired by life sciences equipment giant Illumina. Financial terms of the acquisition were not announced. Illumina said ...

READ MORE...
Tuesday, October 22, 2013

Kona Medical Gets $10M

Menlo Park- and Bellevue, Washington-based medical device manufacturer Kona Medical said Monday that it has raised $10M in a Series D, equity financing round. The round came from Chinese investment firm Morningside Group, which was the sole...

READ MORE...
Friday, October 18, 2013

Breathometer Nabs $2M For Smartphone Breathalyzer

Had too much to drink? Burlingame-based Breathometer, a developer of a breathalyzer which connects to your smartphone, said this week that it has raised $2M in a seed funding round. The round came from Structure Capital VC and Dillon Hill C...

READ MORE...
Thursday, October 17, 2013

Biodesy Gets $15M For Protein Analysis Tools

Burlingame-based Biodesy has raised $15M in a funding round, for its protein analysis systems, the company said this week. According to the company, the Series A funding came from 5AM Ventures, Pfizer Venture Investments, and Roche Venture ...

READ MORE...
Wednesday, October 16, 2013

Veeva Systems Surges in IPO

Pleasanton-based Veeva, a developer of cloud-based software for the life sciences industry, surged its its IPO, and is now trading as high as $38.00--up 85 percent from its IPO price of $20.00 per share. The company--which is backed by Emer...

READ MORE...
Wednesday, October 9, 2013

Amaranth Medical Gets $20M

Mountain View-based Amaranth Medical, which is developing bioresorbable, coronary scaffolds use for treating coronary artery disease, said this week it has raised $20M in a Series B funding. The funding came from DCP Management of Singapore...

READ MORE...
Tuesday, October 8, 2013

Personalis Raises $22M For Genome Sequencing

Menlo Park-based Personalis, a developer of genome sequencing and interpretation services, has raised $22M in its Series B financing round. The company has now raised over $42M for its services. The new funds were led by Abingworth Manageme...

READ MORE...
Monday, October 7, 2013

Boreal Genomics Gets $18M For Cancer Profiling

Los Altos-based Boreal Genomics, a developer of scientific equipment used to detect and monitor mustations in plasma due to cancer, said last week that it has raised $18M in a Series C funding round. The funding came from Arch Venture Partn...

READ MORE...
Monday, September 30, 2013

Relypsa Files For IPO

Redwood City-based Relypsa has filed for an IPO, saying that it is looking to raise up to $126.5M in its initial public offering on the NASDAQ Global Market. The company, which is developing non-absorbed polymeric drugs to treat disorders i...

READ MORE...
Friday, September 27, 2013

SafeShot Gets $6M

Menlo Park-based SafeShot Technologies, a developer of medical technology designed to pre-fill medications into syringes, has raised $6M in a funding round. The company said the funding came on top of an earlier, $3M funding it completed in...

READ MORE...
Thursday, September 26, 2013

Neurotrack Taps Into $2M

Palo Alto-based Neurotrack announced today that it has raised $2M in a Series A funding round. The funding came from Founders Fund, and also included The Social+Capital Partnership. Neurotrack is working on biomarker technology to help diag...

READ MORE...
Wednesday, September 25, 2013

Simplee Looks To Tame Medical Bills With $10M In Funding

Palo Alto-based health startup Simplee is trying to help patients better manage and understand their medical bills, and now has $10M to help in its quest. The company said this week that it has raised $10M in a Series B funding, led by Heri...

READ MORE...
Tuesday, September 24, 2013

Practice Fusion Finds $70M More

San Francisco-based healthcare software provider Practice Fusion said this morning that it has raised $70M in a Series D financing round, bringing its total raised to $134M. The new funding was led by Kleiner Perkins Caufield & Byers, and a...

READ MORE...
Monday, September 23, 2013

Veracyte Files For IPO

South San Francisco-based Veracyte has filed for an IPO, saying that it is looking to raise up to $74.75M in its initial public offering. The company says it plans to debut on the NASDAQ Global Market as VCYT. The company's IPO is being und...

READ MORE...
Tuesday, September 17, 2013

VisionCare Opthalmic Technologies Sees $15M

Saratoga-based VisionCare Opthalmic Technologies, a developer of medical devices to treat end-stage Age-Related Macular Degeneration (AMD), says it has raised $15M in funding in a debt round. According to the company, the capital came from ...

READ MORE...
Wednesday, September 11, 2013

Veeva Systems Files For $150M IPO

Pleasanton-based Veeva, a developer of cloud software for the life sciences industry, has filed for an IPO, and is looking to raise up to $150M on the public markets. The company said it has applied to list on the New York Stock Exchange as...

READ MORE...
Tuesday, August 27, 2013

Sangamo BioSciences Acquires Ceregene

Richmond-based Sangamo BioSciences announced Monday that it is acquiring Ceregene, a biotechnology firm developing adeno-associated virus (AAV) gene therapies. Sangamo said it will issue 100,000 shars of its common stock, plus provide unsp...

READ MORE...
Tuesday, August 27, 2013

Sangamo BioSciences Acquires Ceregene

Richmond-based Sangamo BioSciences announced Monday that it is acquiring Ceregene, a biotechnology firm developing adeno-associated virus (AAV) gene therapies. Sangamo said it will issue 100,000 shars of its common stock, plus provide unsp...

READ MORE...
Monday, August 26, 2013

Onyx Pharmaceuticals Acquired By Amgen For $10.4 Billion

San Francisco-based biopharmaceuticals firm Onyx Pharmaceuticals has been acquired by fellow biotech developer Amgen, in a deal worth $10.4 billion. Amgen said it would pay $125 per share in cash, or $9.7 billion net in estimated cash at ha...

READ MORE...
Monday, July 22, 2013

SynapDx Taps Into Funding From Google For Autism Testing

SynapDX, which is developing blood test to enable diagnosis of Autism Spectrum Disorders (ASD), has raised $15.4M in funding, led by Google Ventures. According to SynapDx, the funding also included North Bridge Venture Partners and General ...

READ MORE...
Monday, July 22, 2013

NGM Biopharmaceuticals Gets $50M For Diabetes, Obesity Treatments

South San Francisco-based NGM Biopharmaceuticals said last week that it has raised $50M in a Series C funding round, to go towards its development of therapeutics for the treatment of diabetes, obesity and other cardio‐metabolic disea...

READ MORE...
Wednesday, July 17, 2013

OncoMed Pharmaceuticals Boosts Shares In IPO Offering

Redwood City-based OncoMed Pharmaceuticals has increased the number of shares it is offering its IPO, boosting the number of shares in its offering to 4.8 million shares. No other terms of the IPO have changed. OncoMed Pharmaceuticals devel...

READ MORE...
Monday, July 15, 2013

Optimedica Acquired By Abbott For $400M

Santa Clara-based Optimedica, a developer of laser-based, opthalmic surgery devices, has been acquired by Abbot Medical Optics in a deal worth $250M in cash, plus up to $150M in earn out milestones. Optimedica is venture backed by Alloy Ven...

READ MORE...
Thursday, July 11, 2013

Comprehend Systems Gets $8.4M

Palo Alto-based Comprehend Systems, which develops software to manage clinical trails, has raised $8.4M, the company said this morning. The Series A funding came from Sequoia Capital, and also included angels Aaron Levie, Nils Johnson, Zod ...

READ MORE...
Thursday, July 11, 2013

Breakthrough Finds $5M

Redwood City-based Breakthrough announced this morning that it has raised $5M in a Series A funding, for its online counseling and psychiatry service. The funding came from Social+Capital Partnership, along with First Round Capital and Grea...

READ MORE...
Wednesday, July 3, 2013

Zyomyx Taps Into $12M For HIV Testing

Fremont-based Zyomyx, a developer of portable, medical diagnostics platforms initially aimed at HIV/AIDs, has raised $12M in a Series 2 funding. The firm said the funding was led by Mylan, and also included conversion of funding from the Bi...

READ MORE...
Tuesday, July 2, 2013

Sequenta Secures $20M For Immune Therapeutics

South San Francisco-based biotechnology developer Sequenta has raised $20M in a Series C funding, the firm said today. Sequenta said the round was led by Foresite Capital Management, and also included Mohr Davidow Ventures and Index Venture...

READ MORE...
Monday, July 1, 2013

Veracyte Gets $28M In Series C For Molecular Diagnostics Products

South San Francisco-based molecular diagnostics firm Veracyte has raised $28M in a Series C funding. The firm said the funding included GE Ventures, as well as Domain Associates, Kleiner Perkins Caufield & Byers, TPG Biotech, and Versant Ve...

READ MORE...
Friday, June 21, 2013

3-V Biosciences Finds $20M

Menlo Park-based 3-V Biosciencs, a biopharmaceuticals firm developing therapeutics for the oncology and infectious disease area, said Friday that it has raised $20M in a series C funding. The funding came from existing investors Kleiner Per...

READ MORE...
Monday, June 17, 2013

ForSight VISION5 Sees $9.3M

Menlo Park-based ForSight VISION5 said Monday that it has closed its $9.3M, Series B-1 funding round. The firm, which is an offshoot of ophthalmic technology incubator Forsight Labs, said VISION5 is focused on treatments for ocular hyperten...

READ MORE...
Thursday, June 13, 2013

Anacor Pharmaceuticals Gets Loan Funding

Palo Alto-based Anacor Pharmaceuticals, a developer of small-molecule therapeutics derived from a boron chemistry platform, has entered into a new, $45.0M loan agreement, the company said this week. The company said the loan comes from Herc...

READ MORE...
Monday, June 10, 2013

Pearl Therapeutics Acquired For $1.15 Billion

Venture backed pharmaceuticals firm Pearl Therapeutics has been acquired by AstraZeneca in a deal worth up to $1.15 billion, the firms said today. Pearl Therappeutics is a developer of inhaled bronchodilator products for the treatment of pa...

READ MORE...
Thursday, May 30, 2013

Mercator MedSystems Gets $6.5M

San Leandro-based Mercator MedSystems has raised $6.5M in a Series B financing, the company announced this morning. Mercator MedSystems said the funding came from Volcano Capital, Crocker Capital, and Aphelion Capital, and also included Win...

READ MORE...
Friday, May 24, 2013

Jennerex Biotherapeutics Gets $21.6M

San Francisco-based Jennerex Biotherapeutics has raised $21.6M in funding, the firm announced Thursday. Source of the private placement was not disclosed. Jennerex is developing oncolytic immunotherapies for solid tumors. The company said t...

READ MORE...
Tuesday, May 21, 2013

ConsultingMD Finds $10M For Medical Advice Service

Palo Alto-based ConsultingMD, which is developing an online service to connect patients with second opinions from medical experts, has raised $10M in a funding round. The round came from Venrock. The company said it will use the funds to fu...

READ MORE...
Thursday, May 2, 2013

Proteus Digital Health Lands $62.5M

Redwood City-based Proteus Digital Health has raised $62.5M in a Series F financing, the firm said Wednesday. The funding came from Oracle, Otsuka, Novartis, Sino Portfolio and the company's other investors. Proteus Health is developing "d...

READ MORE...
Monday, April 29, 2013

Conceptus Acquired By Bayer

Mountain View-based Conceptus, a developer of non-surgical, permanent birth control devices, has been acquired by Bayer Healthcare, the two announced this morning. According to the two, Bayer HealthCare has signed a merger agreement with CO...

READ MORE...
Thursday, April 25, 2013

drchrono Gets Investment From Box

Mountain View-based drchrono, which develops iPad applications for viewing electronic health records (EHR), said Thursday that it has received an investment from cloud storage provider Box. Financial details of the investment were not discl...

READ MORE...
Tuesday, April 23, 2013

Cervel Neurotech Gets $14.1M For Brain Stimulation Devices

San Mateo-based Cervel Neurotech, a developer of medical devices which use magnetic coils to treat psychiatric and neurologic illnesses, said today that it has raised $14.1M in a new funding round. The funding came from D. E. Shaw Ventures ...

READ MORE...
Wednesday, April 10, 2013

iRhythm Taps Into $16M For Heart Rate Monitoring

San Francisco-based iRhythm Technologies, a developer of patch-based, cardiac monitoring products, said today that it has raised $16M in a Series D funding round. The funding was led by Norwest Venture Partners, and also included New Leaf V...

READ MORE...
Tuesday, April 9, 2013

Cleave Biosciences Adds $10M In Series A

Burlingame-based biopharmaceuticals developer Cleave Biosciences has raised another $10M in its Series A funding round, the firm announced today. According to Cleave, the new funding came from New Enterprise Associates. The funding brings i...

READ MORE...
Monday, April 8, 2013

SteadyMed Therapeutics Finds $3M In Working Capital

San Ramon-based SteadyMed Therapeutics, a developer of biopharmaceuticals to treat Pulmonary Arterial Hypertension (PAH), has raised $3M in a term loan from Square 1 Bank. Square 1 Bank said the loan will go towards working capital, to help...

READ MORE...
Tuesday, March 26, 2013

SARcode Bioscience Acquired By Shire

Brisbane, California-based SARcode Bioscience said Monday that it is in an acquisition deal with Shire US Holdings, the global specialty biopharmaceuticals firm. SARcode said that Shire will pay $160M plus additional, undisclosed payments b...

READ MORE...
Tuesday, March 26, 2013

Third Rock Ventures Raises $516M Fund

San Francisco- and Boston-based Third Rock Ventures, which invests in healthcare companies, said Monday that it has raised $516M in its third fund, Third Rock Fund III. The firm said the fund was oversubscribed. The new fund brings its tota...

READ MORE...
Friday, March 1, 2013

CardioKinetix Scores $48M For Heart Failure Treatment

Menlo Park-based CardioKinetix said Thursday that it has raised $48M in a Series E financing, for its catheter-based heart failure therapies. The new funding round came from Panorama Capital, along with prior investors U.S. Venture Partners...

READ MORE...
Friday, March 1, 2013

Solta Medical Completes Sound Surgical Technologies Buy

Hayward-based Solta Medical, the developer of medical aesthetics products, said this week that it has completed its acquisition of Sound Surgical Technologies. The deal was worth $25.5M in Solta common stock, $5.0M in cash, plus up to $9.5M...

READ MORE...
Monday, February 25, 2013

Intersect ENT Gets $30M

Menlo Park-based Intersect ENT, which develops sinus implants used to treat ear, nose and throat patients, said today that it has raised $30M in a Series D round of funding. The round was led by Norwest Venture Partners, and also included ...

READ MORE...
Wednesday, February 20, 2013

Gynesonics Lands $21M In New Funding

Redwood City-based Gynesonics, a developer of minimally invasive products for treating uterine fibroids in women, said today that it has raised $21M in a Series F funding round. The round was led by HBM Partners, and also included Correlati...

READ MORE...
Friday, February 15, 2013

Odyssey Thera Gets $2.8M In Funding

San Ramon-based Odyssey Thera, a developer of technology which measures disease pathways in human cells, said Thursday that it has raised $2.8M in funding. The funding came from HBM Partners, Burrill & Company, and Lonza. According to Odyss...

READ MORE...
Wednesday, January 30, 2013

Solta Medical Buys Sound Surgical Technologies

Hayward-based Solta Medical, which develops medical aesthetics products, has acquired SOund Surgical Technologies, in a deal worth $25.5M in stock, $5.0M in cash, plus up to $9.5M in earnout. Sound Surgical Technologies develops surgical an...

READ MORE...
Wednesday, January 23, 2013

MAP Pharmaceuticals Acquired By Allergan

Mountain View-based MAP Pharmaceuticals, a publicly held developer of biopharmaceuticals aimed at treating migraines in adults, has been acquired by Allergan. The two said that Allergan will pay $25.00 per share for MAP, or approximately $9...

READ MORE...
Tuesday, January 22, 2013

Syapse Gets Funding Round From Social+Capital

Palo Alto-based Syapse, which operates an online repository of human genome and clinical data, said this morning that it has raised a round of funding from The Social+Capital Partnership. Size of the funding round was not disclosed. Syapse ...

READ MORE...
Tuesday, January 8, 2013

Epocrates Acquired By Athenahealth

San Mateo-based Epocrates, the publicly held developer of mobile medical applications, has been acquired by Athenahealth, the two said this week. Athenahealth said it would pay $11.75 per share in cash, or approximately $293M, for Epocrates...

READ MORE...
Monday, January 7, 2013

Solstice Biologics Raises $18M

San Francisco-based Soltice Biologics said Friday that it has raised $18M in a Series A funding round. The firm, which is developing technology that enables the delivery of RNA-based therapeutics across membranes, said the funding was led b...

READ MORE...
Thursday, January 3, 2013

Labrys Biologics Raises $31M

San Francisco-based Labrys Biologics, a biopharmaceuticals firm focused on treatments for chronic migraine, said this morning that it has raised $31M in a Series A financing round. The round came from venBio, Canaan Partners, InterWest Part...

READ MORE...
Wednesday, January 2, 2013

Halt Medical Raises $15M

Livermore-based Halt Medical has raised $15M in a funding round, which will go toward commercialization of its medical devices for treating uterine fibroids, the firm said this morning. Halt Medical said its system was recently cleared by t...

READ MORE...
Friday, December 21, 2012

Ascend Clinical Buys PathCentral's Diagnostics Lab Unit

Redwood City-based Ascend Clinical, a provider of end-stage renal disease laboratory testing, has acquired the diagnostics laboratory business of PathCentral. Financial terms of the buy were not announced. PathCentral provides diagnostics t...

READ MORE...
Wednesday, December 19, 2012

LUMO Bodytech Gets $5M

Palo Alto-based LUMO BodyTech, a developer of sensors, devices, and software which monitors a user's posture to help improve back health and reduce back pain, has raised $5M in a Series A funding round. The round was led by Madrona Venture ...

READ MORE...
Monday, December 17, 2012

Allakos Gets $32M For Antibody Therapeutics

San Mateo-based Allakos said today that it has raised $32M in a Series A financing round, which will go towards its antibody therapeutics for treating allergic and inflammatory diseases. The funding was led by Novo Ventures, and also includ...

READ MORE...
Wednesday, December 12, 2012

23andMe Decodes Another $50M

Mountain View-based 23andMe, the personalized genetics company led by Anne Wojcicki, said yesterday that it has received more than $50M in a new financing round. The round came from new investor Yuri Milner, and also included Sergey Brin, N...

READ MORE...
Wednesday, December 5, 2012

BioCision Gets $2.5M

Larkspur-based BioCision, which develops tools for the life sciences research and clinical research market, said today that it has raised $2.5M in a growth financing round. The round came from BroadOak Capital Partners, along with Research ...

READ MORE...
Tuesday, November 27, 2012

Edison Pharmaceuticals Nabs $20M To Treat Mitochondrial Disease

Mountain View-based Edison Pharmaceuticals, a biopharmaceuticals firm developing treatments for mitochondrial diseases, has raised $20M in a Series F funding. The round was led by Mitsui & Co. Edison said the funding will go to advance clin...

READ MORE...
Tuesday, November 27, 2012

TriReme Medical Lands $18M

Pleasanton-based TriReme Medical, a developer of medical devices for treating peripheral arterial disease, said today that it has raised $18M in a funding round. The round was led by Luminor Capital of Singapore, and also included other, un...

READ MORE...
Thursday, November 15, 2012

Intarcia Therapeutics Gets $210M For Diabetes Treatments

Hayward-based Intarcia Therapeutics announced Thursday that it has raised $210M in a combination of equity and debt. The developer of diabetes treatment said it raised $160M in a preferred stock private placement, and $50M in private debt. ...

READ MORE...
Wednesday, November 14, 2012

Beyond Lucid Finds New Funding

Walnut Creek-based Beyond Lucid, a firm which helps provide tracking of documentation for the emergency response industry, said today that it has raised a "six figure" convertible note from Dalmore Investments. Exact amount of the funding w...

READ MORE...
Wednesday, November 14, 2012

Remedy Informatics Raises $6M

Remedy Informatics, a developer of clinical registries, medical research software, and research informatics for the life sciences industry, has raised $6M. The firm, which has offices in Menlo Park, said the funding came from the Merck Glob...

READ MORE...
Tuesday, November 13, 2012

Pearl Therapeutics Gains $65M

Redwood City-based Pearl Therapeutics said today that it has raised $65M in a Series D funding round. The round came from its existing investors, which include 5AM Ventures, Clarus Ventures, New Leaf Venture Partners, and Vatera Healthcare ...

READ MORE...
Wednesday, November 7, 2012

Drip Drop Finds Funding

San Francisco-based Drip Drop, a developer of medically forumlated, oral rehydration solutions used to treat dehydration and other issues, said today that it has raised a round of equity funding. Size of the funding round was not disclosed....

READ MORE...
Thursday, November 1, 2012

Advanced Cell Diagnostics Gains $12M

Hayward-based Advanced Cell Diagnostics said this morning that it has raised $12M in a Series B funding round. The firm, which is developing automated tools for detecting and quantifying RNA biomarkers, said the round was led by New Leaf Ve...

READ MORE...
Monday, October 29, 2012

Principia Biopharma Finds $12.5M

San Francisco-based Principia Biopharma, a pharmaceuticals firm developing small molecule drugs aimed at treating inflammatory, autoimmune diseases, and cancer, has raised $12.5M in a second tranche of funding. The funding came from New Lea...

READ MORE...
Wednesday, October 10, 2012

Longitude Capital Gets $385M For Life Sciences Fund

Menlo Park-based venture capital investor Longitude Capital said today that it has raised $385M for its second, life sciences fund, Longitude Venture Partners II. The firm said it had targeted the fund at $325M. Longitude invests in growth ...

READ MORE...
Friday, October 5, 2012

KaloBios Pharmaceuticals Files For IPO

South San Francisco-based KaloBios Pharmaceuticals has filed for an IPO, saying that it is looking to raised $60M on the NASDAQ Global Market as KBIO. The firm's IPO is being underwritten by Leerink Swann, William Blair, and Needham & Compa...

READ MORE...
Monday, October 1, 2012

Singulex Files For IPO

Alameda-based Singulex, a developer of diagnostics tests for diagnosing and monitoring chronic diseases, has filed for an IPO, saying that it is looking to raised up to $86.25M on the New York Stock Exchange. The firm, whose initial tests a...

READ MORE...
Thursday, September 20, 2012

MyoKardia Gets $38M For Heart Disease Treatment

San Francisco-based Myokardia, a newly formed developer of small molecule therapeutics, said today that it is targeting genetic heart disease with $38M in funding. The Series A funding came from Third Rock Ventures. MyoKardia is developing ...

READ MORE...
Monday, September 17, 2012

Station X Finds $5M

Redwood City-based Station X, a developer of software used for analyzing and visualizing genome data, has raised $5M in a second round of funding, the firm said today. The funding was led by Runa Capital, and also included Genomic Health. T...

READ MORE...
Monday, September 17, 2012

Complete Genomics Acquired For $117.6M By Chinese Firm

Mountain View-based Complete Genomics has found a buyer for the firm, Chinese company BGI-Shenzhen. the two said this morning. The two said that they have entered into a definitive merger agreement where BGI Biotech will pay $3.15 per share...

READ MORE...
Wednesday, September 5, 2012

Doximity Gets $17M

San Mateo-based Doximity, developer of a mobile app driven, social networking platform for doctors, has raised $17M in funding. The funding was led by Morgenthaler Ventures. The new funding brings its total raised to $27.8M. Doximity is led...

READ MORE...
Tuesday, August 14, 2012

MyHealthTeams Takes $1.75M For Health Social Networks

San Francisco-based MyHealthTeams, which develops online, social networks specifically geared towards patients with individual, chronic health conditions, said today that it has raised $1.75M in a seed funding round. The round was led by Ad...

READ MORE...
Wednesday, August 1, 2012

CytomX Therapeutics Raises $41M

San Francisco-based CytomX Therapeutics, a developer of antibody therapeutics, said Tuesday that it has raised $41M in an expanded, Series B financing round. The round was led by Canaan Partners, and also included Third Rock Ventures and th...

READ MORE...
Tuesday, July 17, 2012

Navigenics Acquired By Life Technologies

San Francisco-based personalized DNA and genetics testing firm Navigenics has been acquired by Life Technologies, a developer of life sciences equipment. Financial terms of the acquisition were not disclosed. Navigenics was venture backed b...

READ MORE...
Wednesday, July 11, 2012

Avinger Gains $33M In Series D

Redwood City-based Avinger, a developer of medical devices used for treating peripheral artery disease (PAD), said yesterday that it has raised $33M in a Series D funding round. The firm said its existing major investors participated in the...

READ MORE...
Monday, July 9, 2012

GenturaDx Acquired By Luminex

Hayward-based GenturaDx, a developer of molecular diagnostics products used for PCR analysis, has been acquired by Luminex Corporation. The deal was worth $50M in cash, plus unspecified earnout. GenturaDx was venture backed by Bay City Capi...

READ MORE...
Friday, June 29, 2012

Benvenue Medical Gets $25M

Santa Clara-based Benvenue Medical, a developer of minimally invasive products used for spine repair, said yesterday that it has raised $25M in a Series D funding round. The round came from existing investors DeNovo Ventures, Domain Associa...

READ MORE...
Thursday, June 28, 2012

Practice Fusion Calls Up $34M For EHR Software

San Francisco-based Practice Fusion, a developer of web-based, electronic medical records (EMR) software, announced this morning that it has raised $34M in a financing round. The round was led by Artis Ventures, and also included Felicis Ve...

READ MORE...
Thursday, June 28, 2012

Gemmus Pharma Gets Series A

San Francisco-based Gemmus Pharma, a developer of treatments for influenza, said today that it has raised a Series A funding. Size of the round was not disclosed. The round was led by Life Science Angels, and also included BlueTree Allied A...

READ MORE...
Thursday, June 28, 2012

Aptus Endosystems Gets $25M

Sunnyvale-based Aptus Endosystems, which is developing medical devices used for endovascular aneurysm repair (EVAR), said Wednesday that it has raised $25M in a equity funding round. The round was led by Synergy Life Science Partners, and ...

READ MORE...
Friday, June 22, 2012

Endogastric Solutions Gains $13M More

Redwood City-based EndoGastric Solutions, a developer of medical devices for treament of Gastroesophageal Reflux Disease (GERD), said Thursday that it has raised $13M in additional funding, a Series F extension for the company. The round c...

READ MORE...
Friday, June 15, 2012

Global Blood Therapeutics Finds $40.7M For Sickle Cell Treatments

San Francisco-based Global Blood Therapeutics said this week that it has raised $40.7M in a Series A financing, for its efforts to develop oral, small molecule drugs for treating conditions such as sickle cell disease. The funding came from...

READ MORE...
Thursday, June 14, 2012

Invuity Lights Up With $25M

San Francisco-based Invuity, which develops surgical illumination and visualization technology, announced this morning that it has raised $25M in a Series D funding round. The funding was led by Valence Advantage Life Sciences Fund II, and ...

READ MORE...
Thursday, June 14, 2012

C8 Medisensors Finds $19M For Glucose Monitors

San Jose-based C8 Medisensors, a developer of medical devices which use light to measure blood glucose levels in people with diabetes, has raised $19M in a preferred stock financing, the firm said this week. Source of the funding was not an...

READ MORE...
Tuesday, June 12, 2012

CellScope Picks Up $1M

San Francisco-based CellScope, a developer of software that uses cellphone cameras to help diagnose pediatric ear infections, has raised $1M in a funding round, the firm said Monday. The seed funding came from Khosla Ventures. CellScope's s...

READ MORE...
Tuesday, June 12, 2012

Igenica Raises $33M For Cancer Antibodies

Burlingame-based Igenica, a developer of biopharmaceuticals focused on the cancer market, has raised $33M in a Series C funding round. The round was led by Third Rock Ventures, and also included The Column Group, Orbimed Advisors and 5AM Ve...

READ MORE...
Monday, June 11, 2012

AliveCor Gets $10.5M

San Francisco-based AliveCor, which develops mobile electrocardiogram (ECG) devices, said today that it has raised $10.5M in a Series B funding round. The round was led by Burrill & Company and Khosla Ventures, and also included Qualcomm Ve...

READ MORE...
Thursday, June 7, 2012

Ringadoc Calls Up $750K

San Francisco-based Ringadoc, a provider of service which allows users to call up doctors for medical device using their phone or computer, has raised $750,000 in a seed funding round. The firm said the funding came from FF Angel, Ryan Howa...

READ MORE...
Tuesday, June 5, 2012

Auxogyn Gets $18M For Women's Health

Menlo Park-based Auxogyn, a developer of health testing technology to test the viability of embryos during in vitro fertilization (IVF), has raised $18M in a Series B funding round, the company said today. The round was led by SR One, and a...

READ MORE...
Tuesday, June 5, 2012

Complete Genomics Chops Staff, Looks For Buyer

Mountain View-based Complete Genomics, the onetime high flying provider of whole human genome sequencing services, said today that it has cuts its staff, and has hired an investment banking firm to assist in "strategic alternatives." The fi...

READ MORE...
Monday, June 4, 2012

SentreHeart Sew Up $26M Round

Redwod City-based SentreHEART, the develope rof a medical device used for suturing soft tissue, has raised $26M in a Series C financing round, the firm announced. The round was led by Vivo Ventures, and also included US Venture Partners and...

READ MORE...
Tuesday, May 22, 2012

PneumRx Buys Assets From Broncus Technologies

Mountain View-based PneumRx, a developer of medical devices for minimally invasive treatment of lung disease, said it has acquired the patents and domain names from Broncus Technologies. Financial terms of the acquisition were not disclosed...

READ MORE...
Wednesday, May 16, 2012

Nurix Raises $3.1M For Biotherapeutics Effort

San Francisco-based Nurix, a stealth mode startup which looks to be headed by Timothy Kutzkey, a venture capitalist at The Column Group, has raised $3.1M in a funding, according to a regulatory filing by the firm. Details on what the compan...

READ MORE...
Friday, May 11, 2012

OncoMed Pharmaceuticals Files For IPO

Redwood City-based OncoMed Pharmaceuticals filed for an IPO Friday, saying that it is looking to raised up to $115M on the NASDAQ Global Market as OMED. The firm's IPO is being underwritten by Jefferies, Leerink Swann, Piper Jaffray, and...

READ MORE...
Thursday, April 19, 2012

SynGen Gets $5M For Stem Cell Harvesting

Sacramento-based SynGen, which is developing stem cell harvesting systems for the regenerative medicine market, has raised $5M in a Series A funding. The round came from Bay City Capital. According to the firms, Bay City Capital will add tw...

READ MORE...
Friday, April 13, 2012

Hyperion Therapeutics Files For IPO

South San Francisco-based Hyperion Therapeutics has filed for an IPO, saying that it is looking to raise up to $57.5M in an IPO on the NASDAQ Global Market. The firm has applied to list as HPTX. Hyperion is a developer of biopharmaceuticals...

READ MORE...
Tuesday, April 10, 2012

KAI Pharmaceuticals Acquired By Amgen For $315M

South San Francisco-based KAI Pharmaceuticals, a biopharmaceuticals firm development treatment of secondary hyperparathroidism in patients with chronic kidney disease on dialysis, has been acquired by Amgen, the firms said today. Amgen said...

READ MORE...
Thursday, March 29, 2012

Oracle Acquires ClearTrial

Redwood Shores-based Oracle said this morning that it has acquired ClearTrial, a developer of cloud-based, clinical trial tracking software. Financial terms of the by were not disclosed. Oracle said that ClearTrial's software helps make the...

READ MORE...
Wednesday, March 28, 2012

Relievant Medsystems Gets $30M

Redwood City-based Relievant MedSystems, a developer of medical devices being targeted at treating low back pain, said today that it has raised $30M in a Series D funding round. The round was led by New Enterprise Associates, and also inclu...

READ MORE...
Monday, March 26, 2012

TheraVida Raises $8.9M

Mountain View-based TheraVida, a developer of drugs to treat overactive bladder and urinary incontinence, has now raised $8.9M in its latest funding round, according to a recent regulatory filing from the firm. Details on the funding have n...

READ MORE...
Wednesday, March 21, 2012

Myoscience Land $33M Funding

Redwood City-based Myoscience, a developer of medical devices which use cold to treat wrinkles, pain, and certain dermatologic conditions, said today that it has raised $33M in a Series D funding round. The round came from Accuitive Medica...

READ MORE...
Tuesday, March 13, 2012

Halt Medical Gains $20M

Livermore-based Halt Medical, a medical devices firm which is developing equipment to treat uterine fibroids, has raised $20M in debt and equity funding. The funding came from American capital, Ltd., along with other affiliates. Terms of th...

READ MORE...
Monday, March 5, 2012

Varian Medical Systems Buys InfiMed

Palo Alto-based Varian Medical Systems, which manufactures medical devices and software for the radiotherapy, radiosurgery, and brachytherapy market, announced today that it has acquired InfiMed, a developer of workstations for processing d...

READ MORE...
Monday, February 13, 2012

Health Fidelity Digs Up Series A

Menlo Park-based Health Fidelity said last week that it has raised a Series A funding round, to apply to its efforts to use natural language processing to mine for clinical healthcare data. The firm did not disclose the size of the funding....

READ MORE...
Monday, February 13, 2012

Halt Medical Nabs $20M

Livermore-based HALT Medical, a developer of medical devices for treating uterine fibroids, announced today that it has raised $20M in the first part of an ongoing, $50M funding round.The firm said the debt and equity funding came from Amer...

READ MORE...
Wednesday, February 8, 2012

Velomedix Finds $10.2M For Treating Heart Attacks, Stroke

Menlo Park-based Velomedix, which is developing medical devices which use hypothermia to treat cardiac arrest and stroke patient, has raised $10.2M in a Series B funding. Source of the funding was not announced by the company. As part of th...

READ MORE...
Thursday, February 2, 2012

Auxogyn Rounds Out Funding Round At $20M

Menlo Park-based Auxogyn, which is developing a system to improve invitro fertilization, said today that it has closed out its Series A round at $20M. According to the firm, the final tranche of its Series A included Kleiner Perkins Caufiel...

READ MORE...
Monday, January 30, 2012

drchrono Collects $2.8M

Mountain View-based drchrono, a developer of mobile healthcare software, including electronic health records, prescription, medical billing, and patient management tools, said last week that it has raised $2.8M in a funding round. The round...

READ MORE...
Monday, January 30, 2012

Glooko Gets $3.5M From Angels

Palo Alto-based Glooko, a developer of a mobile application and cables to pull and log information from glucose meters for the diabetic, has raised $3.5M in a Series A funding. The round came from The Social+Capital Partnership, along with ...

READ MORE...
Tuesday, January 24, 2012

VisionCare Opthalmic Expands Series E

Saratoga-based VisionCare Opthalmic Technologies has closed an expansion of the firm's Series E financing, the company said this week. The funding was led by Agate Medical Investments. Size of the round was not disclosed. As part of the fun...

READ MORE...
Wednesday, January 11, 2012

Practice Fusion Lands $2M More

San Francisco-based Practice Fusion, which develops electronic medical records, said this morning that it has raised $2M more in funding for the company. The funding came from angels Jed Stremel (Facebook), Ali Partovi (LinkExchange), and H...

READ MORE...
Monday, January 9, 2012

Avinger Gets $22.5M

Redwood City-based Avinger, a maker of multi-functional catheters used for patients with Peripheral Artery Disease (PAD), said today that it has closed on $22.5M in a Series C funding. The round came from its existing investors, along with ...

READ MORE...
Monday, January 9, 2012

Aria Diagnotics Gets $52.7M

San Jose-based Aria Diagnostics, a developer of molecular diagnostic test for prenatal and maternal health, reported this morning that it has raised $52.7M in a Series C funding round. The round came from Meritech Capital Partners, an un-na...

READ MORE...
Friday, January 6, 2012

3-V Biosciences Finds $20M In Funding

Menlo Park-based 3-V Biosciences, which is developing treatments for Hepatitus C (HCV), said this week that it has closed a preferred round of funding, worht a minimum of $20M. The round came from Kleiner Perkins Caufield & Byers and New En...

READ MORE...
Wednesday, January 4, 2012

Bionovo Gains $5M

Emeryville-based Bionovo, a publicly held developer of pharmaceuticals for treating both menopause and cancer, said yesterday that it has raised $5M in a private investment. The funding came from Socius CG II, Ltd, a Bermuda-based investmen...

READ MORE...
Wednesday, December 28, 2011

PharmacoFore Lands $10M

San Carlos-based PharmacoFore, a biopharmaceuticals firm working on compounds to treat diseases of the central and peripheral nervous systems, said Tuesday that it has raised $10M in an equity funding round. The round came from the Founders...

READ MORE...
Tuesday, December 13, 2011

IntegenX Lands $40M

Pleasanton-based IntegenX, which is developing rapid human DNA identification technology, said this morning that it has raised $40M in a Series C funding. The funding was led by Essex Woodlands, and also included Domain Associates, QuestMar...

READ MORE...
Friday, December 9, 2011

Hansen Medical Gets $30M In Debt Funding

Mountain View-based Hansen Medical, a publicly traded developer of robotic catheters, said Friday that it has raised $30M in a debt facility. The funding came from Oxford Finance and Silicon Valley Bank. Hansen Medical said the financing wi...

READ MORE...
Tuesday, December 6, 2011

HealthTap Gets $11.5M For Health Questions Site

Palo Alto-based HealthTap, a new startup which allows users to ask any health question online, and get an answer from a real doctor for free, announced today that it has raised $11.5M in a Series A funding. The funding was led by Mayfield F...

READ MORE...
Thursday, December 1, 2011

Affymetrix Buys eBioscience

Santa Clara-based Affymetrix said Wednesday that it is acquiring eBioScience, a privately held developer of flow cytometry and immunoassay reagents for immunology and oncology research and diagnostics. The deal was worth $330M in cash. Priv...

READ MORE...
Tuesday, November 29, 2011

Tegal Invests $300K In Israeli Medical Devices Firm

Petaluma-based Tegal, a developer of a wide range of semiconductor and MEMs devices and technology, said this morning that it has invested $300,000 in NanoVibronix, an Israeli ultrasound technology developer. NanoVibronix is developing low-...

READ MORE...
Tuesday, November 22, 2011

BARRX Medical Acquired By Covidien

Sunnyvale-based BARRX Medical, a developer of minimally invasive medical devices, said yesterday that it has agreed to be acquired by Coviden. The deal is worth approximately $325M, plus future earn out. BARRX develops endoscopy devices use...

READ MORE...
Monday, November 21, 2011

Portola Pharmaceuticals Raises $89M

South San Francisco-based Portola Pharmaceuticals announced Monday that it has raised $89M in a preferred stock financing round. The firm, which is developing therapeutics aimed at cardiovascular and autoimmune/inflammatory disease, said th...

READ MORE...
Monday, November 14, 2011

LiveLeaf Harvests $2.6M

San Carlos-based Live Leaf Biosciences, a startup developing plant-based treatments for diarrheal disease, antibiotic alternatives, and wound care, has raised $2.6M in a funding round, according to a regulatory filing from the firm. Detail...

READ MORE...
Wednesday, November 9, 2011

Pivot Medical Finds $32M

Sunnyvale-based Pivot Medical, a developer of minimally invasive technologies for hip arthroscopy, said Tuesday that it has raised $32M in a series C funding round. The round was led by Adams Street Partners, and also included Delphi Ventu...

READ MORE...
Tuesday, November 8, 2011

Comprehend Systems Gets $1.2M In Seed Funding

Palo Alto-based Comprehend, a developer of clinical data visualization, analytics, and reporting software for the clinical research industry, said today that it has raised $1.2M in a seed funding round. The round came from Y Combinator, S...

READ MORE...
Tuesday, November 8, 2011

DFINE Lands $25M

San Jose-based DFINE, a developer of minimally invasive radiofrequency therapies for treating vertebral fractures, announced today that it has raised $25M in a funding round. The funding came from OrbiMed Advisors, Prospect Venture Partners...

READ MORE...
Thursday, October 27, 2011

Solta Medical Expands Credit Line

Hayward-based Solta Medical, a developer of medical aesthetics products, said this week that it has expanded a credit line from Silicon Valley Bank. The firm said it has expanded the line from $18M to $28M, with the new $10m under a secured...

READ MORE...
Wednesday, October 26, 2011

Ziosoft Acquired By Nantworks

Redwood City-based Ziosoft, a developer of software used for 4D and 5d medical imaging on supercomputers, has been acquired by Nantworks, a technology incubation and development firm run by Patrick Soon-Shiong, a billionaire investor in Los...

READ MORE...
Monday, October 24, 2011

Eric Schmidt Backs Pharmaceuticals Authentication Firm

Eric Schmidt, the Executive Chairman and former CEO of Google, has backed an Indian developer of pharmaceuticals security technology. According to PharmaSecure, a developer of anti-counterfeiting technology for pharmaceuticals, it raised $3...

READ MORE...
Thursday, October 20, 2011

goBalto Gets Series A

San Francisco-based goBalto, a developer of web-based, clinical research software, said today that it has raised an undisclosed amount of Series A financing. The Series A came from Aberdare Ventures and the West Health Investment Fund. A re...

READ MORE...
Friday, October 7, 2011

ZELTIQ Aesthetics Sets IPO Range

Pleasanton-based ZELTIQ Aesthetics, the developer of an aesthetic medical product used for selectively reducing fat bulges, has set its initial IPO range, according to an updated S-1 from the company today. ZELTIQ said it estimates its IPO ...

READ MORE...
Wednesday, October 5, 2011

SV Life Sciences Names New Venture Partner

SV Life Sciences, the venture capital investment firm with offices in Boston, San Francisco, and London, said Wednesday afternoon that it ha named Dr. Heiner Dreismann as a new Ventuer Partners. Dr. Dreismann has previously served at Roche ...

READ MORE...
Tuesday, September 27, 2011

SpineGuard Raises $6.2M

San Francisco-based SpineGuard, a developer of a medical device used by surgeons for minimally invasive spine surgery, said Tuesday that it has raised $6.2M in a funding round. The funding came from Credit Agricole Private Equity, Innoven P...

READ MORE...
Monday, September 26, 2011

SI-BONE Scores $16.0M

San Jose-based SI-BONE, which develops a minimally invasive surgical devices for treating the sacroiliac joint, said this morning that it has raised $16.0M in a financing round. The firm said the funds will go towards expansion of its clini...

READ MORE...
Thursday, September 22, 2011

CardioKinetix Gets $44M

Redwood City-based CardioKinetix, the developer of transcatheter implants used to treat patients with heart failure, has raised $44M, the firm said, in a Series E financing round. The funding came via two tranches, and was led by SV Life Sc...

READ MORE...
Tuesday, September 20, 2011

Varian Buys Calypso Medical

Palo Alto-based Varian Medical Systems and Seattle-based Calypso Medical Technologies said Monday that Varian is acquiring Calypso for $10M, plus potential earnout. Calpyso is a developer of tumor tracking and motion management systems for ...

READ MORE...
Tuesday, September 20, 2011

Practice Fusion Raises $6M More

San Francisco-based Practice Fusion, a developer of electronic health records software, said today that it has raised $6M in a new funding round. The round came from Western Technology Investment, Scott Banister, Founders Fund, Morgenthaler...

READ MORE...
Tuesday, September 13, 2011

Edison Pharmaceuticals Lands Series E

Mountain View-based Edison Pharmaceuticals, a developer of treatments for inherited mitochondrial diseases and other rare and neglected diseases, said today that it has raised a Series E preferred financing round. Financial details of the f...

READ MORE...
Friday, September 9, 2011

Crescendo Bioscience Lands $56M

South San Francisco-based Crescendo Bioscience, which develops molecular diagnostic tests for rheumatoid arthritis and other inflammatory diseases, said today that it has raised $31M in a Series C equity funding, plus a $25M strategic inves...

READ MORE...
Wednesday, August 31, 2011

Ardelyx Raises $30M

Fremont-based Ardelyx, a biopharmaceuticals firm developing treatments for irritable bowel syndrome, kidney disease, and diabetes, said Tuesday that it has raised $30M in a Series B funding round. The round included New Enterprise Associate...

READ MORE...
Wednesday, August 24, 2011

Kleiner Funds Healthcare Systems Firm

Kleiner Perkins Caufield & Byers is the lead investor in a developer of real time, location systems for the healthcare market. In an unusual move for Kleiner, the firm was a new investor in a Series F funding round for Awarepoint, who syste...

READ MORE...
Thursday, August 11, 2011

Restoration Robotics Gets $41M

Mountain View-based Restoration Robotics, a medical device firm developing technology for harvesting hair follicles during hair restoration procedures, said last week that it has raised $41M in a Series C financing round. The round was led ...

READ MORE...
Wednesday, August 10, 2011

Second Genome Digests Series A

San Francisco-based Second Genome, a firm developing microbial-based, personalized medicine products for the gastrointestinal disease area, said yesterday that it has raised $5M in a funding round. The round was co-led by Advanced Technolog...

READ MORE...
Tuesday, August 9, 2011

Verinata Health Gains $48.5M

San Carlos-based Verinata Health, a firm developing diagnostic test for monitoring maternal and fetal health, announced today that it has raised $48.5M in a Series C funding round. The firm said the round was led by Mohr Davidow Ventures, S...

READ MORE...
Monday, August 1, 2011

Intuity Medical Raises $76M

Sunnyvale-based Intuity Medical announced this morning that it has raised $76M in funding, in a second close of a previously announced Series D funding. The new funding added Accuitive Medical Ventures, which joins the firm's prior investor...

READ MORE...
Monday, July 18, 2011

SARcode Bioscience Gets $44M

Brisbane-based SARcode Bioscience, a firm developing treatments for inflammatory disease, said this morning it has raised $44M in a Series B financing round. The round was led by Sofinnova Ventures, and also included Rho Ventures, Alta Part...

READ MORE...
Friday, July 15, 2011

Transcend Medical Sees $51M

Menlo Park-based Transcend Medical, which is developing opthalmic devices for treating glaucoma, has raised $51M in its Series B round, the firm said this week. The new funding came as part of a second tranche in the Series B round. The fir...

READ MORE...
Thursday, June 30, 2011

Sorbent Therapeutics Gains $36M

Sunnyvale-based Sorbent Therapeutics, a biopharmaceuticals firm targeting the cardiovascular and renal disease area, has raised $36M in a Series B financing round. The firm said the funding was led by Novartis Venture Funds, and includes ex...

READ MORE...
Monday, June 27, 2011

Redwood Bioscience Gets Funding

Burlingame-based Redwood Bioscience, a firm focused on antibody-drug conjugates and peptide therapeutics, said today that it has secured new funding from Takeda Venturse. Amount of the funding was not disclosed. The firm said the funding wi...

READ MORE...
Friday, June 24, 2011

BioMarin Buys Plant From Pfizer

Novato-based BioMarin Pharmaceutical said Thursday that it is in a deal to buy a 133,000 square foot, bulk biologics manufacturing plant from Pfizer. the plant is located in Shanbally, Cork, Ireland. BioMarin said it paid $48.5M for the pla...

READ MORE...
Monday, June 20, 2011

Ultragenyx Raises $45M

Novato-based Ultragenx Pharmaceuticals said today that it has raised $45M in a Series A funding round. The round was led by TPG Biotech and Fidelity Biosciences, and also included HealthCap and Pappas Ventures. According to the firm, the fu...

READ MORE...
Tuesday, June 7, 2011

PolyRemedy Adds $20M

Mountain View-based PolyRemedy, a developer of chronic wound care treatment systems, said today that it has raised $20M in a Series C funding round. The round was led by Delphi Ventures, and also included prior investors Advanced Technology...

READ MORE...
Wednesday, June 1, 2011

ADVANCE Medical Raises $6M

Palo Alto-based ADVANCE MEdical, which is helping to commercialize pharmaceuticals and medical device technologies in Brazil and other Latin American countries, said Wednesday that it has raised $6M in a Series A financing round. The round ...

READ MORE...
Tuesday, May 31, 2011

CoolSystems Finds $4.0M

Alameda-based CoolSystems, the maker of an cold therapy system aimed at the athletics market, has raised $4.0M in what looks to be a convertible debt round still in progress. Details on the funding have not been announced by the company. Ac...

READ MORE...
Thursday, May 12, 2011

Cell Biosciences Acquires Canadian Firm

Santa Clara-based Cell Biosciences, a developer of scientific equipment for protein analysis, said Thursday that it has acquired Brightwell Technologies, in a deal worth $9M in cash. Brightwell was based in Ottawa, Ontario, and develops mic...

READ MORE...
Monday, May 9, 2011

U-Systems Gets $6.5M

Sunnyvale-based U-Systems, a developer of ultrasound technology for breast imaging, said today that it has raised another $6.5M in funding. The firm said the new funding came from existing investors, which include iD SoftCapital Group, Lumi...

READ MORE...
Wednesday, May 4, 2011

Crown Biosciences Scores $28.8M

Santa Clara-based Crown Biosciences, a provider of clinical testing services for the oncology pharmaceuticals development market, said this mornign that it has raised $28.8M in a Series C financing round. The roun was led by OrbiMed Advisor...

READ MORE...
Tuesday, May 3, 2011

OncoHealth Gets $1.6M For Cervical Cancer Testing

Redwood City-based OncoHealth, a developer of tests for cervical cancer and other cancers caused by human papillomavirus (HPV) viruses, has raised $1.6M in a Series A investment, the firm said today. The funding included Sand Hill Angels, B...

READ MORE...
Friday, April 29, 2011

Xlumena Gains $7M

Mountain View-based Xlumena, a developer of medical devices for the endoscopy market, said last night that it has raised $7M in a Series B financing round. The round was led by Aperture Venture Partners, and also included Western Technology...

READ MORE...
Thursday, April 21, 2011

AngioScore Finds $12M

Fremont-based AngioScore, a developer of angioplasty catheters, said Wednesday that it has raised $12M in new private equity financing. The financing game from Saints Capital, and also included Psilos Group Managers, Telegraph Hill Partners...

READ MORE...
Monday, April 18, 2011

Benvenue Medical Raises $35.5M

Santa Clara-based Benvenue Medical, which is developing minimally invasive products for spine repair, has raised $35.5M in a Series C funding roudn, the firm said today. The funding was co-led by Domain Associates and Technology Partners, a...

READ MORE...
Wednesday, April 13, 2011

Nfocus Neuromedical Gets $7.5M

Palo Alto-based Nfocus Neuromedical, a firm developing treatments for brain aneurysms, has raised $7.5M as part of an ongonig, $12.5M funding round, according to a regulatory filing by the firm this week. No detail on the new funding was di...

READ MORE...
Wednesday, April 13, 2011

GoBalto Raises $2.87M

San Francisco-based GoBalto, a startup developing web-based software for managing clinical trials, has raised $2.87M out of a $3.5M fundraising round. The funding was revealed in a recent regulatory filing. GoBalto is headed by Jae Chung. T...

READ MORE...
Wednesday, April 6, 2011

Oraya Therapeutics Raises $15.875M

Newark, California-based Oraya Therapeutics, a developer of noninvasive, robotically controlled systems for treating eye disorders, has raised another $15.875M in funding, according to a regulatory filing by the firm. The round comes on $5....

READ MORE...
Tuesday, April 5, 2011

Practice Fusion Raises $23M For Electronic Health Records

San Francisco-based Practice Fusion said earlier today that it has raised $23M in a Series B funding round. The provider of electronic health and medical records software said the funding was led by Founders Fund, and also included Artis Ca...

READ MORE...
Wednesday, March 16, 2011

Doximity Connects To $10.8M

San Mateo-based Doximity, a health technology firm developing a service which allows doctors to use their iPhone, iPad, or Android device to connect with other physicians on patient treatment and referrals, has raised $10.8M in a Series A f...

READ MORE...
Thursday, March 3, 2011

Tibion Corp Lands $10.175M

Sunnyvale-based Tibion Corp., a developer of bionic legs for stroke victims, said yesterday that it has raised $10.175M in a new funding round. The funding was led by Three Arch Partners and Hambrecht & Quist Capital Management. As part of ...

READ MORE...
Tuesday, March 1, 2011

Plexxikon Acquired For Up To $935M

Berkeley-based Plexxikon, a developer of drugs for the treatment of melanoma cancer with the oncogenic BRAF mutation, has been acquired by Daiichi Sankyo, in a deal worth up to $935M. The firms said that Japanese pharmaceutical firm Daiichi...

READ MORE...
Monday, February 28, 2011

Intuity Medical Nabs $20M In Credit Line

Sunnyvale-based Intuity Medical, a developer of technologies for diabetes management, said today that it has secured a $20M credit facility from Silicon Valley Bank and Oxford Finance. The firm said the debt funding will go towards completi...

READ MORE...
Tuesday, February 22, 2011

Gilead Sciences Buys Calistoga Pharmaceuticals

Foster City-based Gilead Sciences said today that it is acquiring Calistoga Pharmaceuticals, a Seattle developer of inflammatory, autoimmune, and cancer drugs. Gilead will pay $375M plus up to $225M in earnout for Calistoga. Calistoga was v...

READ MORE...
Tuesday, February 15, 2011

Sonoma Orthopedic Products Raises $22M

Santa Rosa-based Sonoma Orthopedic Products, a developer of medical devices for treating fractures, said Monday that it has raised $22M in a Series D funding round. The round was led by Ascension Health Ventures, and also included Split Roc...

READ MORE...
Monday, February 7, 2011

IntegenX Raises $15.6M

Pleasanton-based IntegenX, a provider of equipment used for preparing DNA and RNA samples for genetic analysis, said last week that it has raised $15.6M in a round of financing, and acquired GenVault Corporation. The funding round was led b...

READ MORE...
Thursday, February 3, 2011

Massive Health Gets $2.25M

San Francisco-based Massive Health, a stealth mode health care firm looking to apply crowdsourcing, game mechanics, and social networking to the healthcare field, has raised $2.25M in a seed funding round. The firm said the funding came fro...

READ MORE...
Wednesday, February 2, 2011

Epocrates Surges In IPO Debut

San Mateo-based Epocrates surged in its IPO debut Wednesday, up to $21.42 after debuting on the NASDAQ as EPOC Wednesday morning at $16.00 per share. The firm sold 5,360,000 shares of its common stock. The IPO was underwritten by J.P. Morga...

READ MORE...
Friday, January 28, 2011

Fluidigm Sets IPO Pricing Range

South San Francisco-based Fluidigm has set the pricing range on its IPO, saying today in a filing with the SEC that it expects to offer 5,172,414 shares of its common stock at between $13.50 and $15.50 per share. Fluidigm is planning to lis...

READ MORE...
Monday, January 10, 2011

VisionCare Ophthalmic Sees $31M More

Saratoga-based VisionCare Opthalmic Technologies, which develops visual prosthetic devices designed to improve vision in patients with end-stage age-related macular degeneration (AMD), said this morning that it has raised another $31M in a ...

READ MORE...
Tuesday, January 4, 2011

PneumRx Gets $33M

Mountain View-based PneumRx, a developer of medical devices for treating lung disease, said today that it has raised $33M in working capital commitments. According to the firm, the new funding was led by Forbion Capital Partners and Endeavo...

READ MORE...
Monday, December 13, 2010

Pipeline Healthcare Raises $2.5M

San Francisco-based Pipeline Healthcare, a provider of remote order entry and other pharmacy services delivered via phone to North American hospitals and retail pharmacies, said Friday that it had raised $2.5M in a funding round. The fundin...

READ MORE...
Monday, December 13, 2010

QuantaLife Gets $17.2M

Pleasanton-based QuantaLife, a developer of PCR equipment for the genetic sequencing market, said Friday that it has raised $17.2M in a Series B financing round. The round came from Paladin Capital Group, Merieux Developpement, and Vital Fi...

READ MORE...
Wednesday, December 8, 2010

Sequenta Raises $13M

San Francisco-based Sequenta, a developer of a molecular diagnostics platform focused on immune system profiling, said today that it has raised $13M in a Series B funding round. The round came from Index Ventures, Mohr Davidow Ventures, and...

READ MORE...
Tuesday, December 7, 2010

Estech Finds $8.5M

San Ramon-based Estech, a developer of a minimally invasive cardiac ablation surgical platform, said today that it has raised $8.5M in a funding round. The funding came from Saints Capital Everest, Telegraph Hill Partners, NBGI Ventures and...

READ MORE...
Monday, November 22, 2010

Sadra Medical Acquired By Boston Scientific

Los Gatos-based Sadra Medical, a developer of a fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis, has been acquired by Boston Scientific, the firms said Friday afternoon. Ac...

READ MORE...
Wednesday, November 17, 2010

Sutro Biopharma Gets $36.5M

San Francisco-based Sutro Biopharma, a developer of protein therapeutics technology, said today that it has raised $36.5M in a Series C funding round. The round was led by Skyline Ventures, and also included Lilly ventures, Amgen Ventures, ...

READ MORE...
Monday, November 15, 2010

AcelRX Files For IPO

Redwood City-based AcelRX Pharmaceuticals has filed for an IPO, saying in a filing with the SEC late Friday that it is looking to raise up to $86.25M on the NASDAQ Global Market. The firm said it is looking to list as ACRX. The IPO is being...

READ MORE...
Wednesday, November 10, 2010

Complete Genomics Prices IPO

Mountain View-based Complete Genomics, a provider of gene sequencing services, has priced its IPO, saying in a filing Wednesday afternoon that it expects its initial public offering price to be $9.00 per share, and will offer up 6 million s...

READ MORE...
Thursday, November 4, 2010

Thoratec Sells ITC To Warburg Pincus

Pleasanton-based Thoratec said today that it has sold its International Technidyne Corporation (ITC) division to private equity firm Warburg Pincus. The deal was worth $55M in cash. Thoratec said the sale will allow it to focus on its exist...

READ MORE...
Monday, November 1, 2010

Gene Security Network Snags $12M More

Redwood City-based Gene Security Network, a provider of molecular diagnostics products for single cell testing for chromosome abnormalities and genetic diseases, said today that it has raised $12M in a Series C funding round. The round was ...

READ MORE...
Monday, November 1, 2010

Vascular Pathways Gets $14M

Los Altos-based Vascular Pathways, a developer of medical devices targeted at peripheral intravenous access, said today that it has raised $14M in a Series B funding round. The round was led by CHL Medical Partners, and also included Ascens...

READ MORE...
Monday, November 1, 2010

McKesson Buys US Oncology

San Francisco-based healthcare services and IT firm McKesson Corporation said today that it is buying Texas-based US Oncology, an operator of cancer treatment centers. The deal is worth $2.16 billion in cash. McKesson said that the oncology...

READ MORE...
Thursday, October 28, 2010

Nellix Acquired By Endologix

Mountain View-based Nellix, a developer of treatments for abdominal aortic aneurysms, has been acquired. According to acquiring firm Endologix, it will pay $15M in stock plus up to $39M in milestone payments for Nellix. As part of the fundi...

READ MORE...
Tuesday, October 26, 2010

Complete Genomics Sets IPO Pricing Range

Mountain View-based Complete Genomics, a provide of gene sequencing services, has set a pricing range for its IPO. The firm, which is looking to list on the NASDAQ Global Market as GNOM, said it expects its public offering price to be betwe...

READ MORE...
Tuesday, October 19, 2010

Pearl Therapeutics Gets $69M

Redwood City-based Pearl Therapeutics, a developer of biopharmaceuticals for treating chronic obstructive pulmonary disease (COPD) and other chronic respiratory diseases, announced this morning that it has raised $69M in a Series C financin...

READ MORE...
Monday, October 18, 2010

Solta Medical Buys CLRS Technology

Hayward-based Solta Medical, a developer of medical aethetics products, said today that it has acquired CLRS Technology, a provider of personal care solutions. Solta said it will pay approximately $1.1M of debt at closing, plus potential fu...

READ MORE...
Wednesday, October 13, 2010

Cell Biosciences Acquires Convergent Bioscience, Raises Funding

Santa Clara-based Cell Biosciences announced this morning that it has agreed to acquire Convergent Bioscience Ltd., a Toronto-based developer of protein analysis products, in a deal worth $12M. According to Convergent, the acquisition will ...

READ MORE...
Monday, October 11, 2010

TriReme Medical Gains $17M In Series D

Pleasanton-based TriReme Medical, a developer of catheter and stent products, said today that it has raised $17M in a Series D funding round. The round was led by Bio*One Capital, and also included current investors Three Arch Partners and ...

READ MORE...
Wednesday, October 6, 2010

Pathwork Diagnostics Scores $30M

Redwood City-based Pathwork Diagnostics, a developer of molecular diagnostics aimed at the oncology market, said today that it has raised $30M in a Series C financing round. The round was led by Alta Partners, and also included prior invest...

READ MORE...
Friday, October 1, 2010

VantagePoint Backs Phreesia

Silicon Valley venture capital firm VantagePoint Venture Partners has backed a New York-based developer of software for managing the patient check-in process for medical offices, Phreesia. Phreesia said VantagePoint led its $20M, Series D r...

READ MORE...
Thursday, September 23, 2010

CytomX Gets $30M

San Francisco-based CytomX Therapeutics, a firm developing antibody technology, announced Thursday that it has raised $30M in a Series B funding round. The round was led by Third Rock Ventures, and also included the Roche Venture Fund. As p...

READ MORE...
Monday, September 20, 2010

Asthmatx Acquired By Boston Scientific

Sunnyvale-based Asthmatx, a developer of a less invastive, catheter-based bronchial thermoplasty procedure for the treatment of severe persistent asthma, has been acquired by Boston Scientific, in a deal worth $193.5M in cash plus up to $25...

READ MORE...
Wednesday, September 15, 2010

Third Rock Ventures Raises $426M Fund, Sets Up Shop In San Francisco

Boston-based Third Rock Ventures, a venture firm focused on life science companies, said this week that it has closed on Third Rock Fund II, a $426M fund focused on the life science area, and also opened up a San Francisco office. According...

READ MORE...
Monday, September 13, 2010

Relypsa Nabs $70M

Santa Clara-based Relypsa, a firm developing non-absorbable polymeric drugs for treating renal impairment, hypertension, diabetes and heart failure, said Monday that it has raised $70M in a Series B funding round. The round was led by OrbiM...

READ MORE...
Monday, September 13, 2010

Anacor Pharmaceuticals Files For IPO

Palo Alto-based Anacor Pharmaceuticals, a biopharmaceuticals firm developing small-molecule therapeutics, has filed for an IPO. According to the firm's filing with the SEC, it is looking to raise up to $86.25M in an IPO on the NASDAQ Global...

READ MORE...
Monday, September 13, 2010

TRIA Beauty Raises $15.6M

Dublin, California-based TRIA Beauty, a developer of light-based skincare products based on lasers, said late last week that it raised $15.6M in a new round of growth financing. According to the firm, the round came from Aisling Capital, De...

READ MORE...
Wednesday, September 8, 2010

Sofinnova Ventures Adds General Partner

Menlo Park-based venture capital firm Sofinnova Ventures announced today that it has added Garheng Kong, M.D., Ph.D., as a General Partners. Kong joins the company from Intersouth Partners, where he was also a General Partner. According to ...

READ MORE...
Monday, August 30, 2010

EndoGastric Solutions Raises $30M

Redwood City-based EndoGastric Solutions, a developer of treatments for upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD), announced this morning that it has raised $30M in a Series F financing round. The fun...

READ MORE...
Thursday, August 26, 2010

Solazyme Adds Strategic Investor

South San Francisco-based Solazyme, which is developing biotechnology that uses algae to produce renewable oil and bioproducts, said Thursday that it has added Bunge Limited as a strategic investors in its Series D round. Amount of the inve...

READ MORE...
Thursday, August 19, 2010

Complete Genomics Gets $39M

Mountain View-based Complete Genomics, a firm developing and commercializing a DNA sequencing platform, said today that it has raised $39M in a Series E funding round. The round was led by Sands Capital, and also included prior investors Es...

READ MORE...
Wednesday, August 18, 2010

BioMarin Buys ZyStor Therapeutics

Novato-based BioMarin Pharmaceuticals said last night that it has acquired ZyStor Therapeutics, a biotech firm developing enzyme replacement therapies for treating lysosomal storage disorders. The deal is worth $22M upfront plus up to $93M ...

READ MORE...
Wednesday, August 18, 2010

SI-BONE Gets $11M

San Jose-based SI-BONE, a medical device firm developing a minimally invasive surgical device to treat the sacroiliac (SI) joint, said late Tuesday that it has raised $11.0M in a financing round. The round came from new investor Skyline Ven...

READ MORE...
Tuesday, August 17, 2010

Ion Torrent Acquired By Life Technologies

Ion Torrent, a developer of DNA sequencing technology, has been acquired by DNA giant Life Technologies, in a deal worth $375M in cash and stock plus up to $350M in earnout. Ion Torrent, which has offices in South San Francisco and headquar...

READ MORE...
Monday, August 16, 2010

Solstice Neurosciences Acquired

Solstice Neurosciences, a firm which as its production and manufacturing in San Francisco, but is based out of Malvern, PA, has been acquired. According to Kentucky-based US Worldmeds, it has acquired Solstice Neuroscience for $35M. US Worl...

READ MORE...
Monday, August 16, 2010

Pacific Biosystems Files For IPO

Menlo Park-based Pacific Biosystems, a developer of tools for DNA, RNA, and protein analysis, has filed for an IPO. According to an S-1 filed by the firm this morning, it is looking to raise up to $200M on the NASDAQ Global Market as PACB. ...

READ MORE...
Friday, August 6, 2010

Neodyne Stitches Up $5.8M

Menlo Park-based Neodyne Biosciences, a stealth mode biotechnology firm developing technology related to plastic surgery and wound care, has raised $5.8M in funding, according to a recent regulatory filing. No details on the firm, nor its f...

READ MORE...
Friday, August 6, 2010

Tenaxis Medical Raises $9.56M

Palo Alto-based Tenaxis Medical, a developer of surgical sealants, has raised $9.56M in a new round of funding, according to a regulatory filing by the firm this week. The funding appears to be part of an ongoing, $16.6M funding round for t...

READ MORE...
Monday, August 2, 2010

Complete Genomics Files For IPO

Mountain View-based Complete Genomics, a provider of human genome sequencing services, said Friday that it has filed for an $86.25M IPO. The firm said it is looking to trade as GNOM on the Nasdaq. The IPO is being underwritten by UBS Invest...

READ MORE...
Tuesday, July 27, 2010

Thoratec Aborts ITC Sale

Pleasanton-based Thoratec, a developer of ventricular assistant devices for patients with heart failure, said today that it has terminated its agreement to sell its International Technidyne Corporation (ITC) division to Danaher Corporation....

READ MORE...
Monday, July 19, 2010

Epocrates Files For IPO

San Mateo-based Epocrates, a provider of drug reference information via mobile phones, has re-filed for an IPO. The firm said it is looking to raise up to $75M on the NASDAQ Global Market under the symbol "EPOC". The IPO is being underwritt...

READ MORE...
Thursday, July 15, 2010

Pacific Biosciences Gains $109M

Menlo Park-based Pacific Biosciences, a firm developing technology for the real-time detection of biological events, said Wednesday that it has completed a $109M, Series F financing. The round includes a previously announced $50m investment...

READ MORE...
Wednesday, July 14, 2010

BARRX Medical Gets $15M

Sunnyvale-based BARRX Medical, a developer of treatments for Barrett's esophagas, a precancerous condition of the esophagus, said today that it has raised $15M in a Series D funding round. The round was led by Highland Capital Partners, and...

READ MORE...
Tuesday, July 13, 2010

Trivascular Raises $60M

Santa Rosa-based Trivascular, a developer of medical stent graft systems for treating aortic aneurysms, said this week that it has raised $60M in a Series C funding round. The round was led by Pinnacle Ventures, and also included New Enterp...

READ MORE...
Tuesday, July 13, 2010

Ventus Medical Gains $40M

Belmont-based Ventus Medical, a medical device firm developing a treatment for sleep apnea, said this week that it has raised $40M in a Series D funding round. Source of the new funding was not disclosed. Ventus also said it has named Peter...

READ MORE...
Friday, July 9, 2010

iPierian Nets $22M

South San Francisco-based iPierian, a firm developing stem cell-based biopharmaceuticals for the drug discovery market, said Thursday that it has raised $22M in a Series B equity funding. The round was led by Google Ventures, and also inclu...

READ MORE...
Thursday, July 8, 2010

DFine Pulls In $36M

San Jose-based DFine, which develops minimally invasive treatments for stabilizing vertebral fractures, said this week that it has raised $36.2M in a new round of funding. The round was led by Split Rock Partners, and also included Orbimed,...

READ MORE...
Thursday, July 8, 2010

Calithera Biosciences Raises $40M

South San Francisco-based Calithera Biosciences said today that it has raised $40M in a Series A financing round. The round was led by Morgenthaler Ventures, and also included U.S. Venture Partners, Advanced Technology Ventures, Delphi Vent...

READ MORE...
Monday, June 21, 2010

Incline Therapeutics Gets $43M

Redwood City-based Incline Therapeutics, a specialty pharmaceuticals firm developing a transdermal, patient-controlled analgesia system for post-surgey patients, has scored $43M in a Series A venture financing. The firm said Monday that the...

READ MORE...
Thursday, June 17, 2010

Pacific Biosciences Raises $50M

Menlo Park-based Pacific Biosciences, a developer of DNA sequencing technology, has received $50M in an investment from Gen-Probe, the firms announced Thursday. According to the firm, the investment comes as part of a deal to co-develop new...

READ MORE...
Tuesday, June 15, 2010

Practice Fusion Adds Goines To Board

San Francisco-based Practice Fusion, a developer of electronic medical records software, said today that it has added angel investor and former Intuit exec Mark Goines to is baord of directors. Goines was most recently Senior Vice President...

READ MORE...
Friday, June 11, 2010

Veracyte Gets $28M

South San Francisco-based Veracyte, a developer of molecular cytology diagnostic products, has raised $28M in a Series B round. The round was led by Domain Associates, and also included Kleiner Perkins Caufield & Byers, TPG Biotech, and Ver...

READ MORE...
Friday, June 11, 2010

Castlight Health Snags $60M

San Francisco-based Castlight Health, which delivers a web-based service to provide employees with information about health care benefits and costs, has raised $60M in a Series C funding. The firm said the round came from Morgan Stanley Inv...

READ MORE...
Thursday, June 10, 2010

Quark Pharmaceuticals Raises $10M

Fremont-based Quark Pharmaceuticals, a developer of RNAi-based therapeutic products, announced Thursday that it has raised $10M in a funding round. The round came from Japanese firm SBI Holdings Group. As part of the funding, Quark said it ...

READ MORE...
Thursday, June 3, 2010

Zeltiq Raises $25M In Series D

Pleasanton-based Zeltiq, a firm developing medical devices for fat reduction, announced yesterday that it has raised $25M in a Series D funding round. The round was led by Aisling Capital, and also included its prior investors Advanced Tech...

READ MORE...
Thursday, May 27, 2010

Alexza Gets $25M In Financing Facility

Mountain View-based Alexza Pharmaceuticals, a publicly held firm focused on treatment of central nervous system conditions, said today it has received a committed equity financing facility worth $25M. The funding comes from Azimuth Opporuni...

READ MORE...
Wednesday, May 19, 2010

Breathe Technologies Inhales In $23M More

San Ramon-based Breathe Technologies, a developer of medical devices for trating chronic obstructive pulmonary disease and sleep apnea, said Tuesday that it has raised $23M in a Series C funding round. The round was led by DAG Ventures, and...

READ MORE...
Thursday, May 13, 2010

iRhythm Technologies Snags $10M

San Francisco-based iRhythm Technologies, which develops a cardiac rhythm monitor, has scored $10M in a funding from St. Jude Medical, Mohr Davidow Ventures, and Synergy Life Science Partners, St. Jude and iRhythm announced Thursday. Accord...

READ MORE...
Tuesday, May 11, 2010

Intuit Buys Medfusion

Mountain View-based Intuit said Monday evening that it has acquired Medfusion, a North Carolina-based firm providing online software for healthcare providers. The deal was worth $91M in cash. According to Intuit, the acquisition will accele...

READ MORE...
Friday, April 30, 2010

NeurogesX Gets $40M In Royalty Financing

San Mateo-based NeurogesX, a biopharmaceuticals firm focused on pain management, said today that it has entered into a $40M royalty financing agreement, from Cowen Healthcare Royalty Partners, L.P. According to the firm, the debt funding wi...

READ MORE...
Thursday, April 29, 2010

Viveve Gets $4.0M

Palo Alto-based Viveve, a firm developing non-surgical, vaginal tissue restoration technology for women, has received $4.0M in a funding round, according to a regulatory filing from the firm this week. The firm is backed by 5AM Ventures and...

READ MORE...
Tuesday, April 27, 2010

Healthline Looks Up $14M

San Francisco-based Healthline Networks, which operates consumer related health information web sites, announced Tuesday that it has raised $14M in a third roudn of funding. The round was led by Investor Growth Capital. Peacock Equity Fund ...

READ MORE...
Thursday, April 22, 2010

Codexis Prices IPO

Redwood City-based Codexis, a developer of biocatalysts for the pharmaceutical and biofuels industries, said today that it has priced its IPO at $13.00 a share. The firm is selling 6,000,000 shares of its common stock on the NASDAQ Global M...

READ MORE...
Friday, April 16, 2010

Oracle Buys Phase Forward

Redwood Shores-based Oracle said Friday that it has acquired publicly held Phase Forward, a developer of software-as-a-service applications for collecting clinical trial data. Oracle said it would pay approximately $685M, or $17.00 per shar...

READ MORE...
Friday, April 9, 2010

Amplyx Pharmaceuticals Absorbs $1.5M

Menlo Park-based Amplyx Pharmaceuticals announced Thursday that the firm has raised $1.5M in a Series A funding round. According to the firm, the round came from Golden Seeds, a nationwide angel group investing in women-led companies, with ...

READ MORE...
Friday, April 9, 2010

IRIDEX Buys Ophthalmology Products from RetinaLabs

Mountain View-based IRIDEX Corporation, a developer of laser-based medical devices, said today that it has acquired the ophthalmology products of RetinaLabs, based in Atlanta. According to IRIDIX, the acquisition covers substantially all of...

READ MORE...
Wednesday, April 7, 2010

Achaogen Takes $56M In Series C Round

San Francisco-based Achaogen, a biopharmaceuticals firm focused on developing antibiotics, announced today that it has raised $56M in a Series C round. The round was led by Frazier Healthcare Ventures, and included Alta Partners, 5 AM Ventu...

READ MORE...
Monday, April 5, 2010

Altheos Sees $20M In Series A

South San Francisco-based Altheos announced today that it has raised $20M in a Series A funding. The firm, which is licensing a set of compounds from Japanese firm Asahi Kasei Pharma for the topical treatment of glaucoma, said the funding w...

READ MORE...
Thursday, March 25, 2010

U-Systems Raises $10M

Sunnyvale-based U-Systems, a developer of automated breast ultrasound systems, announced Thursday afternoon that it has raised $10M in a funding round. The round was led by iD SoftCapital Group, and also included Sycamore Ventures, Lumira C...

READ MORE...
Wednesday, March 24, 2010

Allocade Raises $5M

Menlo Park-based Allocade, which develops healthcare software, said Wednesday that the firm has raised $5M in a venture funding round. The round was led by VantagePoint Venture Partners. Allocde said the funding will use to scale the firm's...

READ MORE...
Tuesday, March 16, 2010

Poniard Pharmaceuticals Scores $6.3M

South San Francisco-based Poinard Pharmaceuticals, a publicly held biopharmaceuticals firm, said today that it has raised $6.3M in a share sale to Commerce Court Small Cap Value Fund, Ltd. The firm said the funding will go to fund continued...

READ MORE...
Monday, March 15, 2010

NGM Biopharmaceuticals Get $51M

South San Francisco-based NGM Biopharmaceuticals said today that it has closed on the first tranche of a $51, Series B round of funding. The round came from The Column Group, Tichenor Ventures, LLC, Prospect Venture Partners, Rho Ventures, ...

READ MORE...
Wednesday, March 10, 2010

Eureka Genomics Gets $3.7M

Hercules, California-based Eureka Genomics, a firm focused on using advanced bioinformatics analysis of genetic sequencing data to develop drugs, said Wednesday that it has raised $3.7M in a round of funding from private individuals and ang...

READ MORE...
Wednesday, March 10, 2010

Facet Biotech Acquired By Abbott

Redwood City-based Facet Biotech, a developer of treatments for multiple sclerosis, has been acquired by Abbott, in a deal worth $450M. According to Abbott, it will pay $27 per share in cash for Facet, for a purchase price of approximately ...

READ MORE...
Thursday, March 4, 2010

Vaxart Gets $12.5M For Oral Vaccines

San Francisco-based Vaxart, a developer of oral vaccines, said today that it has raised $12.5M in a Series B funding round. The round was led by Care Capital. As part of the funding, Richard Markham and Jan Leschly of Care Capital have join...

READ MORE...
Tuesday, March 2, 2010

Gold Standard Diagnostics Snags Series A

Davis-based Gold Standard Diagnostics, a firm providing tools for the medical research and laboratory diagnostics industry, said Tuesday that it has raised a Series A round of funding. Amount of the funding was not disclosed. The firm said ...

READ MORE...
Tuesday, February 9, 2010

TwoF Nabs $2.1M

San Mateo-based TwoF, a developer of proprietary technology for production of DNA microarrays, has raised $2.1M in an ongoing, $3.0M funding round, according to a regulatory filing by the firm this week. No details on the funding have been ...

READ MORE...
Tuesday, February 2, 2010

DNA Direct Acquired By Medco Health Solutions

San Francisco-based Mb>DNA Direct, a provider of information about genetics testing, has been acquired by New Jersey firm Medco Health Solutions. Financial terms of the buy were not disclosed. DNA Direct was venture backed by Firefly Invest...

READ MORE...
Wednesday, January 27, 2010

Juvaris Gets Strategic Funding

Pleasanton-based Juvaris Therapeutics, which is developing adjuvanted vaccines for improving the effectiveness of influenza vaccination, said today that it has had a second close of its Series B funding worth up to $25M. The new funding cam...

READ MORE...
Friday, January 15, 2010

Vaxart Gets $3.5M

San Francisco-based Vaxart, a developer of oral vaccines, has raised nearly $3.5M out of an ongoing $12.5M funding round, the firm disclosed in a regulatory filing Thursday. Source of the new funding was not disclosed. The firm's pipeline ...

READ MORE...
Thursday, January 14, 2010

The Foundry Gets $3M For New Medical Device Firm

Menlo Park medical device company incubator The Foundry reported Wednesday that it has received $3M in a Series A financing for its twelfth new company. Name of the new company--refereed to as "Foundry Newco XII"--was not disclosed. Accordi...

READ MORE...
Thursday, January 14, 2010

The Foundry Gets $3M For New Medical Device Firm

Menlo Park medical device company incubator The Foundry reported Wednesday that it has received $3M in a Series A financing for its twelfth new company. Name of the new company--refereed to as "Foundry Newco XII"--was not disclosed. Accordi...

READ MORE...
Tuesday, January 12, 2010

Dfine Gets $2.83M

San Jose-based Dfine, a developer of medical devices for treating spine fractures, has raised $2.83M out of an ongoing, $3.0M funding raising effort, according to a regulatory filing by the firm Monday. No details on the funding have been a...

READ MORE...
Monday, January 11, 2010

Neuralieve Raises $3.89M

Sunnyvale-based Neuralieve, a developer of a medical device for relieving migraine pain, has raised $3.89M out of an ongoing $7.5M fundraise, according to a regulatory filing by the firm. Source of the new funding was not disclosed, however...

READ MORE...
Monday, January 4, 2010

Revance Confirms $25M Fundraising

Newark-based Revance Therapeutics announced today that it has raised $25M in the first close of a $35M, Series D financing round, confirming information first disclosed in a regulatory filing last week. According to Revance, the new funding...

READ MORE...
Monday, December 28, 2009

ReVance Therapeutics Nabs $25.62

Mountain View-based ReVance Therapeutics has raised $25.62M in a Series D funding, according to a regulatory filing by the firm last week. Source of the new funding was not disclosed. ReVance has previously received funding from Bio*One Cap...

READ MORE...
Wednesday, December 16, 2009

Afferent Pharmaceuticals Raises $23M

Palo Alto-based Afferent Pharmaceuticals, a developer of chronic pain treatments, has raised $23M in a Series A financing round, the firm said today. The round was led by Third Rock Ventures and Pappas Ventures, and also included Domain Ass...

READ MORE...
Friday, December 11, 2009

Monterey Devices Gets $2.5M

Soquel-based Monterey Devices, a stealth mode developer of a drug delivery system, has raised $2.5M out of a $7.0M funding round, according to a regulatory filing by the firm this week. The firm lists a representative of MOntage Capital, a ...

READ MORE...
Tuesday, December 8, 2009

Francisco Partners Buy Quadramed

San Francisco-based private equity firm Francisco Partners reported Tuesday that it is acquiring QuadraMed Corporation, a provider of healthcare information technologies and services. The deal is worth approximately $126M in cash. Francisco...

READ MORE...
Monday, December 7, 2009

5AM Ventures Closes $200M Life Sciences Fund

Menlo Park-based 5AM Venture Management said Monday that it has raised $200M in 5AM Ventures III, L.P., the firm's venture capital fund focused on early-stage life sciences companies. The firm said the funding came from both current and new...

READ MORE...
Monday, November 30, 2009

EndoGastric Solutions Gets $21.5M

Redwood City-based EndoGastric Solutions, a developer of medical devices for treating gastroesophageal reflux disease (GERD), has raised $21.5M in a Series E funding round. The funding came from current investors. The company said that the ...

READ MORE...
Friday, November 20, 2009

Trivascular Snags $30M

Santa Rosa-based TriVascular, a developer of stent graft treatments for abdominal and thoracic aortic disease, said this week that it has raised $30M in a Series B funding round. The firm said the funding came from New Enterprise Associates...

READ MORE...
Thursday, November 12, 2009

Microchip Biotechnologies Gains $18.1M

Pleasanton-based Microchip Biotechnologies, a developer of scientific equipment for sample processing in the life sciences and applied sciences area, announced today that it has raised $18.1M in a Series B financing. The round was led by Do...

READ MORE...
Monday, November 9, 2009

Labcyte Gets $5.5M In Venture Debt

Sunnyvale-based Labcyte, a developer of liquid handling equipment and lab instrumentation, has raised $5.5M in a venture debt funding. According to funding firm Hercules Technology Growth Capital, it provided the $5.5M as a credit facility ...

READ MORE...
Thursday, November 5, 2009

Spinal Modulation Gets $27.4M

Menlo Park-based Spinal Modulation, a developer of medical devices for treating back pain, said Thursday that it has raised $27.4M in a Series C funding round. The round came from Johnson & Johnson Development Corporation, DeNovo Ventures, ...

READ MORE...
Friday, October 30, 2009

Mytrus Raises $1.0M

Mill Valley-based Mytrus, a stealth mode firm which says it is "bringing clinical trials directly to participants," has raised $1.0M in a funding round, according to regulatory filings. No details on the funding have been released by the co...

READ MORE...
Friday, October 30, 2009

Nodality Gains $3.5M

South San Francisco-based Nodality has raised $3.5M out of an ongoing, $10M fundraising effort, according to a regulatory filing by the firm this week. The firm is developing personal diagnostics technology, specifically focused on detectin...

READ MORE...
Tuesday, October 20, 2009

Aviir Gets $1.0M

Palo Alto-based Aviir, a firm developing diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease based on research out of Stanford, has raised $1.0M in a combination of equity and debt, along with warrants. The ...

READ MORE...
Monday, October 12, 2009

Onyx Pharmaceuticals Acquires Proteolix

Emeryville-based Onyx Pharmaceuticals said today that it is in a definitive agreement to acquire South San Francisco-based Proteolix, a biopharmaceuticals firm focused on treating hematological malignancies and solid tumors. Onyx said it wi...

READ MORE...
Wednesday, October 7, 2009

Caring.com Buys Senior Housing Directory

San Mateo-based Caring.com, which operates an online site about healthcare options and senior care for aging parents, said Wednesday that it has acquired Gilbert Guide, an online senior housing guide and homecare directory, as well as a pro...

READ MORE...
Tuesday, October 6, 2009

Direct Flow Medical Gets $40M

Santa Rosa-based Direct Flow Medical, a developer of aortic tissue value prothesis, has scored $40M in a venture funding round, according to a regulatory filing by the firm. No details on the funding have been announced by the company. The ...

READ MORE...
Thursday, October 1, 2009

Google Ventures Into Adimab

Mountain View-based Google Ventures, the venture capital arm of Google, has led an investment in Adimab, a New Hampshire firm focused on human antibody discovery. According to Adimab, Google was joined by Polaris Ventures, SV Life Sciences,...

READ MORE...
Monday, September 21, 2009

Jennerex Closes $5.5M Series C

San Francisco-based Jennerex, a developer of oncolytic virus therapeutics, said late last week that it has closed its second tranche of Series C funding. The firm said the round close dout at $5,611,475, above the firm's target of $5M. The ...

READ MORE...
Thursday, September 17, 2009

Juvaris BioTherapeutics Finds $25M

Burlingame-based Juvaris BioTherapeutics announced Thursday that the firm had a first close on a $25M, Series B financing round. The new funding was led by SV Life Sciences and Kleiner Perkins Caufield & Byers. The firm did not say what the...

READ MORE...
Thursday, September 17, 2009

NextBio Nabs $8M

Cupertino-based NextBio, which is developing an online platform for sharing information between life science researchers, said today that it has closed an $8M, Series C venture funding round. The round was led by Newbury Ventures, and also ...

READ MORE...
Tuesday, September 15, 2009

Alvine Pharmaceuticals Gains $21.5M

San Carlos-based Alvine Pharmaceuticals, a biopharmaceuticals firm developing treatments for celiac disease, announced Tuesday that it has raised $21.5M in a Series A extension funding round. The funding was led by Panorama Capital, and als...

READ MORE...
Friday, September 11, 2009

Evalve Acquired By Abbott

Menlo Park-based Evalve, a developer of minimally invasive cardiac valve repair technology, has been acquired by Abbott. Abbott said it would pay $320M in cash plus milestone payments, worth up to a total of $410M, for Evalve. Evalve was fo...

READ MORE...
Thursday, September 10, 2009

VitaPath Genetics Gets $6M

Foster City-based VitaPath Genetics, which is developing molecular diagnostics for detecting Spina Bifida, said today that it has raised $6M in a Series A funding round. The round was led by MDV-Mohr Davidow Ventures, and also included fun...

READ MORE...
Wednesday, September 9, 2009

Cell Biosciences Buys Alpha Innotech, Raises $19M

Santa Clara-based Cell Biosciences said late Tuesday that it has acquired Alpha Innotech Corp in a deal worth approximately $17.9M in cash. San Leandro-based Alpha Innotech develops digital imaging systems for genomic and proteomic research...

READ MORE...
Friday, September 4, 2009

Biogen Idec Launches Hostile Bid For Facet

Biogen Idec said Friday that it has launched an effort to acquire Redwood City-based Facet Biotech, in a deal worth $14.50 per share in cash for Facet. According to Biogen Idec, the offer is approximately 64% over the September 3rd closing ...

READ MORE...
Wednesday, September 2, 2009

Advanced Cell Diagnostics Gets $5.4M

Hayward-based Advanced Cell Diagnostics (ACD), a developer of cell- and tissue-based diagnostic tests for personalized medicine, announced late Wednesday that the firm has completed a second close on a $5.4M, Series A funding. The financing...

READ MORE...
Tuesday, September 1, 2009

Fluidigm Raises $10.7M

South San Francisco-based Fluidigm, a developer of integrated fluidic circuits for the life sciences industry, has raised $10.67M in a funding round, according to a regulatory filing by the firm today. The round is part of a ongoing, $14M f...

READ MORE...
Tuesday, September 1, 2009

Athena Feminine Technologies Raises $2M

Emeryville-based Athena Feminine Technologies, which is developing treatments for female incontinence, announced today that the firm has raised $2M in a Series A investment round. The round came from vSpring Capital. The firm said that the ...

READ MORE...
Monday, August 24, 2009

Complete Genomics Raises $45M

Mountain View-based Complete Genomics said today that it has raised $45M in a Series D financing round. The round was led by Essex Woodlands Health Ventures and OrbiMed Advisors, with existing investors Enterprise Partners Venture Capital, ...

READ MORE...
Thursday, August 20, 2009

OptiMedica Gets $25M

Santa Clara-based OptiMedica, a firm developing medical laser technology for treating retinal disease, has raised $25M as part of a Series D funding round. The funding was disclosed in a regulatory filing. According to the filing, the firm ...

READ MORE...
Thursday, August 13, 2009

Jennerex Raises $5M

San Francisco-based Jennerex, a biopharmaceuticals firm developing oncolytic virus therapeutics targeted at treatment of liver, colon, and lung cancer, said this week that it has raised $5.1M in a funding round as part of a private placemen...

READ MORE...
Friday, August 7, 2009

Practice Fusion Gets Investment From Salesforce.com

San Francisco-based Practice Fusion, a developer of web-based applications for patient health record tracking, disclosed this week that the firm has raised a round of funding from Salesforce.com. Amount of the investment was not disclosed. ...

READ MORE...
Wednesday, August 5, 2009

XDx Adds $14.4M

Brisbane-based XDx, a firm working on molecular diagnostics, reported Wednesday that it has raised $14.4M in a Series G financing round. The round was led by Bristol-Myers Squibb, along with prior investors Burrill Venture Capital; Duff, Ac...

READ MORE...
Wednesday, July 22, 2009

Signostics Sees $4M More

Signostics, which also has operations in Australia and an office in Palo Alto, said late Tuesday that it has raised $4M for the firm's personal ultrasound devices. The firm said the funding round came from Brandon Capital Partners, Playford...

READ MORE...
Tuesday, July 21, 2009

Novasys Medical Raises $18.95M

Newark-based Novasys Medical, which develops a treatment for female stress urinary incontinence, reported today that it has raised $18.95M in a second tranche of its Series D funding round. The funding came from Versant Ventures, ThreeArch ...

READ MORE...
Wednesday, July 15, 2009

Limerick BioPharma Gains $15M

South San Francisco-based Limerick BioPharma reported today that it has raised $15M in a Series C funding round. The round was led by OVP Venture Partners, and also included prior investors ARCH Venture Partners, Sevin Rosen Funds and Altit...

READ MORE...
Thursday, July 9, 2009

Presidio Pharmaceuticals Adds $27M

San Francisco-based Presidio Pharmaceuticals said Thursday afternoon that it has raised another $27M for the firm. The company, which is focused on developing treatments for viral infections, including HIV-1 and HCV, said the round included...

READ MORE...
Wednesday, July 8, 2009

Zosano Pharma Raises $30M

Fremont-based Zosano Pharma, which develops transdermal drug delivery technology, said today that it has raised $30M in a new roun dof financing. Zosano said that Nomura Phase4 Ventures led the round, with all of its existing investors part...

READ MORE...
Wednesday, July 8, 2009

iZumi Bio, Pierian Merge, Gain Investment

South San Francisco-bsaed iZumi Bio and Boston-based Pierian, two biotech firms focused on stem cell based therapeutics, said today that they have merged to form a new company, iPierian, and also raised funding worth $11.5M. The two said th...

READ MORE...
Tuesday, July 7, 2009

Relievant Medsystems Raises $20M

Redwood City-based Relievant Medsystems reports today that it has raised $20M in a private equity financing round. According to Relievant, the round was led by Morgenthaler Ventures, and also included Canaan Partners, ONSET Ventures, and Em...

READ MORE...
Monday, July 6, 2009

Hyperion Therapeutics Raises $60M

South San Francisco-based Hyperion Therapeutics, which is developing pharmaceuticals for the gastroenterology and hepatology areas, announced today that it has raised $60M in a Series C financing round. The round was led by Bay City Capital...

READ MORE...
Thursday, July 2, 2009

5AM Ventures III Reaches $159.25M

Menlo Park-based 5AM Ventures, a venture investor in the life sciences industry, has now hit $159.25M in its fundraising for 5AM Ventures III, according to a regulatory filing from the firm today. Details on limited partners in the fund hav...

READ MORE...
Thursday, July 2, 2009

SpineGuard Gets $4M

San Francisco- and Paris-based SpineGuard, which is developing medical devices for back surgery, said this morning that it has raised $4M in a funding round from Delta Partners. According to the firm, the investment brings its Series A fund...

READ MORE...
Thursday, June 18, 2009

Google Invests $2.6M In 23andMe

Mountain View-based Google disclosed Thursday in a regulatory filing that the firm has invested $2.6M in 23andMe, the genetic analysis firm headed by Sergey Brin's wife, Anne Wojcicki. According to Google, the investment came in 23andMe's S...

READ MORE...
Thursday, June 18, 2009

Oracle Buys Assets From Conformia

Redwood Shores-based Oracle said late Wednesday that the firm has acquired the intellectual property assets of Conformia Software. Financial terms of the acquisition were not disclosed. Conformia is a developer of product and process lifecy...

READ MORE...
Thursday, June 11, 2009

Alios Biopharma Raises $32M

South San Francisco-based Alios BioPharma disclosed this morning that the firm has raised $32M in a Series A, preferred stock financing for the firm's biotechnology efforts. According to the firm, the round came from new investor SR One, th...

READ MORE...
Tuesday, June 2, 2009

Apieron Lands Series D

Menlo Park-based Apieron revealed Monday that the firm has received commitments from Alliance Technology Ventures, Canaan Partners, Draper Fisher Jurvetson and Onset Ventures--all existing investors in the firm--for a Series D round. Fundin...

READ MORE...
Tuesday, June 2, 2009

Versartis Raises $11M

Redwood City-based Versartis, a new joint venture between Amunix Inc. and Index Ventures, said today that it has raised $11M in a Series A financing round. The round came from index Ventures. According to the company, it was created to expl...

READ MORE...
Tuesday, June 2, 2009

Endoscopic Technologies Raises $8M

San Ramon-based Endoscopic Technologies, a developer of cardiac surgery devices, announced today that the firm has raised $8M in a n equity financing raise. According to the firm, the funding was led by NBGI Ventures, and also included Sai...

READ MORE...
Thursday, May 21, 2009

Clovis Oncology Gets $145M

Clovis Oncology, a new biotech startup focused on commercializing anti-cancer agents, disclosed today that it has raised $145M for the firm. The firm, which has offices in San Francisco but is based in Boulder, Colorado, said the funding ca...

READ MORE...
Wednesday, May 6, 2009

Autonomic Technologies Gains $20M

Menlo Park-based Autonomic Technologies, a stealth mode developer of implantable medical devices for treating severe headaches, has raised $20M in a Series B funding, according to lead investor Interwest Partners. Details on the funding hav...

READ MORE...
Wednesday, May 6, 2009

Interwest Discloses First Investments Out Of Fund X

Menlo Park-based venture capital firm Interwest Partners said today that it has made the first four investments from its tenth fund, InterWest X. According to InterWest, it led a $15M Series B financing for Exalt Communications, and co-led ...

READ MORE...
Friday, May 1, 2009

23andMe Gains $11M

Mountain View-based 23andMe, the personal genomics startup headed by Anne Wojcicki, has raised $11M of a $24.26M funding round, silicontap.com has learned. According to a regulatory filing, 23andMe raised the equity on April 16th. Details o...

READ MORE...
Wednesday, April 29, 2009

Google Tracks Swine Flu In Mexico

Mountain View-based Google is looking to apply its search footprint to help track the interest in the swine flu outbreak, through an expansion of its Google Flu Trends service. According to Google, it is now breaking out searches for flu-re...

READ MORE...
Wednesday, April 15, 2009

BiPar Sciences Acquired By Sanofi-aventis

French biotech firm Sanofi-aventis said Wednesday that the firm has signed an agreement to acquire Brisbane, California-based BiPar Sciences. BiPar is a developer of cancer treatments. According to the firms, the deal is worth up to $500M, ...

READ MORE...
Thursday, April 9, 2009

Cell Biosciences Gets $10M

Palo Alto-based Cell Biosciences, a developer of instrumentation systems for the life science industry, announced Thursday that the firm has raised $10M in a Series C round. The round was led by the Wellcome Trust, and also included prior i...

READ MORE...
Tuesday, April 7, 2009

Aerovance Gets $38M

Berkeley-based Aerovance, a biopharmaceuticals firm focused on treatments for respiratory and inflammatory diseases, said Tuesday that it has raised $38M in an equity financing round. According to the firm, the round was led by ProQuest Inv...

READ MORE...
Thursday, March 26, 2009

Neuraltus Pharmaceuticals Finds $17M

Menlo Park-based Neuraltus Pharmaceuticals, which is developing small molecule drugs for treating neurodegenerative diseases, said this morning that it has raised $17M in a Series A financing round. According to the firm, the funding came f...

READ MORE...
Monday, March 23, 2009

Oracle Acquires Relsys International

Redwood City-based Oracle announced this morning that it has agreed to acquire Relsys International, a developer of drug safety and risk management products for the health sciences industry. Financial details of the buy were not disclosed. ...

READ MORE...
Thursday, March 19, 2009

Numerate Raises $5.5M

San Bruno-based Numerate, a biotech firm developing small molecule therapeutics, said Wednesday that it has raised $5.5M in a Series B funding. The company said that Foundation Capital led the round, which also included Lanza techVentures. ...

READ MORE...
Friday, March 13, 2009

23andMe Targets Parkinson's

Mountain View-based 23andMe, the DNA testing startup co-founded by Anne Wojcicki and backed by Google, said Thursday that the firm is launching an effort to help advance research into Parkinson's disease. The firm said that it is in a colla...

READ MORE...
Thursday, March 12, 2009

Stanford Professor Links With Seattle Venture Firm

Irving L. Weissman, M.D., an expert on stem cells, and Director of the Stanford Institute for Cancer/Stem Cell Biology and Medicine, has linked with a venture capital firm based in Seattle. According to OVP Venture Partners, Weissman joins ...

READ MORE...
Thursday, March 12, 2009

Arcxis Biotechnologies Gets Investment From In-Q-Tel

Pleasanton-based Arcxis Biotechnologies, which develops biomedical devices for extracting, isolating, and purifying RNA and DNA, said Thursday afternoon that the firm has scored an investment from In-Q-Tel, the venture capital arm of the CI...

READ MORE...
Tuesday, February 24, 2009

Eiger BioPharma Gets $7.1M

Palo Alto-based Eiger BioPharmaceuticals Inc. announced Tuesday that its first round of venture financing has yielded $7.1 million. The firm credited InterWest Partners and Vivo Ventures with leading the Series A effort. Both investors hel...

READ MORE...
Thursday, February 12, 2009

Alios BioPharma Gains $8.4M

South San Francisco-based Alios BioPharma, which is developing small-molecule and protein-based therapeutics, said Thursday that it has raise $8.4M in a Series A funding round. The firm said the funding is the first tranche in a commitment ...

READ MORE...
Wednesday, February 4, 2009

Linkage Biosciences Gains $2M

San Francisco-based Linkage Biosciences disclosed Wednesday that the firm has raised $2M in a Series A funding round. The round was led by Greenhouse Capital Partners and James R. Fisher, who is a managing member of Fisher Capital Corp. II ...

READ MORE...
Tuesday, February 3, 2009

Guava Technologies Acquired By Millipore

Hayward-based Guava Technologies, which develops bench top cell analysis systems for the life sciences industry, has been acquired by Massachusetts-based Millipore, Millipore said today. According to Millipore, it will pay $22.6M for Guava....

READ MORE...
Friday, January 30, 2009

Arcxis Biotechnologies Gains Series B

Pleasanton-based Arcxis Biotechnologies, which is developing biomedical devices, said Friday that the firm has completed the first close of a Series B funding round. Amount of the funding was not disclosed. Arcxis said that Claremont Creek ...

READ MORE...
Friday, January 30, 2009

Cantimer Gets $1M

Menlo Park-based Cantimer, which is developing senors for measuring human hydration from saliva, said Thursday that it has scored $1M in an equity investment. The funding came from Advanced Instruments Inc., and was part of a deal to collab...

READ MORE...
Friday, January 30, 2009

Omnitura Therapeutics Gets $24M

Redwood Shores-based Omnitura, a biopharmaceutcals firm marketing multivalent drugs for the treatment of cancer, said Thursday that the firm has raised $24M in a private placement. The firm did not disclose investors, but said that the fina...

READ MORE...
Wednesday, January 14, 2009

Avigen Hires Investment Bankers

Alameda-based Avigen said Wednesday that the firm has hired two investment banks to evaluate offers for the firm and its assets. According to the firm, RBC Capital Markets and Pacific Growth Equities LLC will oversee review of merger and ac...

READ MORE...
Wednesday, January 14, 2009

Singulex Gains $19M

Alameda-based Singulex said this week that it has raised $19M in a venture financing round, led by JAFCO Co., Ltd. The firm said that the round also included prior investors Orbimed Advisors and Fisk Ventures. Hironori Hozoji of JAFCO Life ...

READ MORE...
Tuesday, January 13, 2009

BiPar Sciences Raises $20M In Debt, Equity

Brisbane, California-based BiPar Sciences, a biopharmaceuticals firm focused on treatments for breast cancer, said Tuesday morning that it has raised $20M in a combination of equity and venture debt. The firm said the funding came from its ...

READ MORE...
Tuesday, January 13, 2009

Alter-G Gains $8M

Menlo Park-based Alter-G, which develops medical devices for the rehabilitation market, said Tuesday that it has raised $8M in a Series B funding round. The funding came from Versant Ventures. The firm said that Ross Jaffe of Versant Ventur...

READ MORE...
Monday, January 12, 2009

Acclarent Gets $26M

Menlo Park-based Acclarent, which develops medical devices for treating ear, nose, and throat conditions, said today that it has raised $26M in a financing round. The round came from Johnson & Johnson Development Corporation, along with exi...

READ MORE...
Wednesday, January 7, 2009

Gene Security Network Decodes $6M

Redwood City-based Gene Security Network, which develops molecular diagnostics technology to enhance genetic testing, said Wednesday that it has closed on a $6M Series B funding round. The new funding came from current investors Claremont C...

READ MORE...
Wednesday, January 7, 2009

Anacor Pharmaceuticals Takes $50M More

Palo Alto-based Anacor Pharmaceuticals, a developer of small molecule drugs focused on treating fungal, bacterial, and inflammatory diseases, said Tuesday that it has scored another $50M in a preferred stock financing. The funding came from...

READ MORE...
Monday, January 5, 2009

Clarus Ventures Names Partners

South San Francisco- and Cambridge-based venture capital firm Clarus Ventures, LLC, said this morning that it has named two new partners. The firm said that it has promoted Emmett Cunningham to Partner and Scott Requadt as Transactional Par...

READ MORE...
Monday, December 22, 2008

KaloBios Pharmaceuticals Raises $12M

South San Francisco-based KaloBios Pharmaceuticals disclosed Monday that the biotech firm has raised $12M in a second close of its Series D venture funding. According to the firm, the additional capital came from Baxter International Inc. T...

READ MORE...
Thursday, December 18, 2008

SV Life Sciences Names Venture Partner

San Francisco- and Boston-based venture firm SV Life Sciences said Thursday that it has named a new Venture Partner at the firm. The venture capital firm, which makes investments in biotechnology & pharmaceuticals, medical devices & instrum...

READ MORE...
Wednesday, December 10, 2008

DecisionView Lands Series D

San Francisco-based DecisionView, a supplier of software used for managing clinical trials, announced Tuesday that it has closed a Series D investment. The funding round came from Granite Ventures, Adobe Ventures, and Aeris Capital. Amount ...

READ MORE...
Thursday, December 4, 2008

Broncus Technologies Lands $38M

Mountain View-based Broncus Technologies, which is developing medical devices for treating emphysema, said Thursday that it has raised $38M in a Series G Funding. The round was led by Ares Life Sciences AG, which invested $25M in the firm. ...

READ MORE...
Wednesday, November 19, 2008

Arete Therapeutics Lands $16.7M

Hayward-based Arete Therapeutics, which is a biotechnology firm focused on soluble epoxide hydrolase (s-EH) inhibitors, has added $16.7M in a Series A tranche financing. According to Arete, the tranche was led by Frazier Healthcare Ventures...

READ MORE...
Wednesday, November 12, 2008

Panomics Acquired By Affymetrix

Fremont-based Panomics, a developer of genetic assay products, has been acquired by Santa Clara-based Affymetrix, Affymetrix said Tuesday. Affymetrix said it will pay approximately $73M in cash for Panomics. Panomics develops scientific ins...

READ MORE...
Wednesday, October 29, 2008

DFine Raises $30M

San Jose-based DFine, a developer of medical devices for treating vertebral compression fractures, said Tuesday that it has raised $30M in a Series D investment. The new round was led by BBT Fund LP and Highland Capital Management and also ...

READ MORE...
Thursday, October 16, 2008

BioImagene Adds Siemens As Investor

Cupertino-based BioImagene, a developer of digital pathology products, said Thursday that it has added Siemens Venture Capital as a new investor in the firm. BioImagene said that the funding follows the recently close of a $26M Series D fin...

READ MORE...
Tuesday, September 30, 2008

APT Pharmaceuticals Raises $32M

Burlingame-based APT Pharmaceuticals, which is developing treatments for serious lung diseases, said Tuesday that it has raised $32.3M in a Series B funding. The round was led by Three Arch Partners, and also included new investors InterWes...

READ MORE...
Monday, September 22, 2008

Amplyx Pharmaceuticals Raises Series A Funding

Amplyx Pharmaceuticals, a drug development firm developing small molecule drugs, has raised a Series A funding round, worth roughly $700K. The funding came from the Tech Coast Angels and life Science Angels. According to the Tech Coast Ange...

READ MORE...